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ABSTRACT
Damaging and often irreversible effects occurring in aquatic ecosystems have recently
been linked to the presence of pharmaceuticals in water bodies. Because this crisis has only
recently been identified, existing reports on the consequences of this contamination are scarce.
In EPA standard acute effluent toxicity tests, Ceriodaphnia dubia, Daphnia pulex, Pimephales
promelas, Mysidopsis bahia, and Menidia beryllina were subjected to two of the most widely
distributed pharmaceuticals in the U.S., ethinyl estradiol (EE2), a synthetic form of estrogen, and
fluoxetine HCl (FLX), the active ingredient in Prozac®, for 96 hours to assess and evaluate toxic
responses.
After test termination, mortality curves were statistically analyzed to quantify 96 hour
median effective concentrations (EC50s), no observable effect concentrations (NOECs), lowest
observable effect concentrations (LOECs), and chronic values (Ch.V.s).
Derived EC50s for both drugs identified C. dubia as the most sensitive organism. In
terms of the Ch.V., C. dubia was the most sensitive organism administered EE2 and M. bahia
given FLX. The most resilient species was P. promelas regarding the EC50 after EE2 dosing,
D. pulex in respect to the Ch.V. after EE2 dosing, and M. beryllina pertaining to the EC50 and
Ch.V after FLX dosing.
Existing risk assessments and traditional toxicity tests do not incorporate sublethal
effects. Because EE2 and FLX have the potential to alter serotonin, dopamine, and estrogenic
hormones, biological activities encompassing these chemicals could be affected such as changes
in behavior, growth and development, and fecundity. Observations on exposed organisms
indicate that there were sublethal effects. The observed increases in abnormal behaviors of
exposed organisms included unresponsiveness, irregular swim patterns, erratic activity, and
convulsions with observed decreases in feeding habits and aggression. Ethinyl estradiol
xii

appeared to accelerate maturation; elevated concentrations appeared to slightly stimulate
maturity while appearing to inhibit molting. The organisms exposed to higher concentrations of
EE2 and FLX seemed to lack pigment.
Continuous environmental pollution of these unregulated chemicals can cause stress on
aquatic ecosystems and result in disturbances of the normal development and life cycles of
aquatic organisms. If these sublethal disruptions in biological activity continually disregarded,
catastrophic destructions of entire ecosystems could transpire.
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INTRODUCTION
Pharmaceutical substances were designed with the intention of maintaining health and
well being and are used as aids to diagnose, treat, or prevent disease. In order to perform their
intended function, pharmaceuticals are designed with degradation resistance, accumulation
potential, and toxicity potential in terms of effectiveness on biological key functions. However,
through human activity, aquatic ecosystems have been exposed to these chemicals since their
introduction into the market. Although drugs are not considered pollutants, they do fit the
definition. Pollutants may be classified by the following criteria: origin (natural or synthetic),
effects (on organs, species, or entire ecosystems), properties (mobility, persistence, and toxicity),
and ease or difficulty of cleanup and/or removal.
Comparatively little attention has been given to pharmaceuticals as potential
environmental pollutants because they represent a fraction of man-made pollutants (pesticides
and household and personal care products) present in the environment. Additionally, because
their existence has only been recently proven, it is still unclear how these chemicals affect
ecosystems. This does not belittle their potential to cause harm to the environment because
pharmaceuticals are designed to be very efficient in producing a maximum response at a
minimum dose. The environmentally detected amounts of drugs have not been linked to
significant declines in survivorship. As a result, their potential effects on the environment have
gone overlooked. The United States Geological Survey (USGS) has established a baseline for
contaminants of concern (COCs) in which pollutants have the potential to affect the health and
welfare of aquatic ecosystems and humans. Pharmaceuticals with modes of action depending
upon signal transduction, cell division, and key metabolizing enzymes can be hazardous to
nontarget organisms that possess or lack the necessary elements to carry out the drugs function.
The problem is that although pharmaceuticals were not designed to affect organisms, they have
1

been recently linked to damaging sublethal effects of nontarget organisms living downstream of
wastewater treatment plants (WWTPs). Definitive effects need to be identified in order to
develop a solution before effects become out of control and irreversible.
Pharmaceuticals as Pollutants
Every year people use thousands of tons of drugs to treat illnesses, to prevent unwanted
pregnancy, or to face the stresses of modern life. The production and consumption of two of the
most popular pharmaceuticals in the United States, ethinyl estradiol and fluoxetine, are
increasing at an exponential rate. However, environmental concern is not exclusively based on
high production rates; the chemicals’ properties and behavior in the environment should also be
considered. Pharmaceuticals fit the definition of pollutants in which they are introduced in
appreciable amounts, exhibit environmental persistence, and cause damaging effects on
ecosystems (Ritter 2006).
However, they are often discounted as pollutants and they are not regulated by
environmental agencies. Regulations control priority pollutants in wastewater treatment plants’
(WWTPs) effluent but because pharmaceuticals are not classified as priority pollutants they are
not regulated.
Although pharmaceuticals fit the definition of emerging pollutants, they are disregarded
as COCs for a number of reasons. First of all, the production and testing of drugs is under the
Food and Drug Administration (FDA).

Drugs were seldom considered potential environmental

pollutants because the international regulation of pharmaceuticals is regulated by human health
agencies which do not focus on environmental concerns. Thus once the chemical is excreted
from the user, the fate of active pharmaceutical ingredients (APIs) has been disregarded
(Daughton and Ternes 1999). Personal use and excretion of drugs are a less visible source of
these potential contaminants because they are unintentionally emitted into the environment.
2

Pharmaceuticals entering the environment via excretion are under not regulated or monitored by
environmental laws. Resource Conservation and Recovery Act (RCRA) does not regulate any
household waste under the control of consumers, which includes medicational waste (USEPA
2010). Regulations control priority pollutants in WWT effluent but because pharmaceuticals are
not classified as priority pollutants they are not regulated.
Portions of active pharmaceutical ingredients (APIs) that are not fully absorbed by
humans nor completely degraded by metabolic processes are secreted in urine or feces and then
emitted into raw sewage (Halling-Sorensen et al. 1998; Daughton et al. 1999). Primarily through
untreated and treated sewage effluent these compounds have been continuously flowing into the
aquatic environment for as long as people have been taking them. Hence they are present
anywhere that humans visit or live. Because drugs are polar and nonvolatile, they are unable to
escape from the aquatic zone. Aquatic organisms are exposed to pharmaceuticals through the
aforementioned pathway for their entire life-cycle making them susceptible to the chemicals’
effects.
Because they occur in small amounts, their existence has only recently been proven
through advancement in analytical methods. These highly water soluble compounds could not
be analyzed using the normal sample clean-up/preconcentration methods, with gas
chromatographic separation typically used for aquatic pollutants (Daughton et al. 1999). It was
not until the 1990s that analytical methods were substantially advanced with high separatory
efficiencies to detect the low levels of pharmaceuticals in the environment (Daughton and Ternes
1999). With the amounts of pharmaceuticals produced and consumed exponentially increasing it
is difficult to analyze every API. Most pharmaceuticals and their metabolites are not presented
in environmentally oriented mass spectral libraries. Also, any available analytical reference
standards are expensive and difficult to obtain (Daughton and Ternes 1999). In order to
3

minimize environmental contamination, pollution prevention should be favored over remediation
or restoration.
Risk Assessment
Because environmental toxicology focuses on acute effects of exposure, traditional
toxicity tests simply survey mortality; in this way, these tests are oversimplified because they do
not account for body burdens. It should be noted that besides known targets additional or other
target tissues and organs may be affected alternatively. This would result in unexpected effects
not targeted by the typical regulations. Because environmental concentrations are below those
necessary to cause mortality, lethality alone is not a sufficient enough endpoint to determine
potential effects on environment.
Risk assessment is flawed because it does not incorporate body burdens; these chemicals
cause changes not anticipated by human tests due to physiological differences of nontarget
organisms. Traditional toxicity tests usually designate mortality as a significant endpoint and in
a few cases size or reproduction.
More specific toxicity analysis should be developed implementing the available
knowledge generated during the pharmaceutical development process (e.g. pharmacokinetic
behavior and metabolism, probable and possible modes of action, target organs and tissues, and
side effects in mammals). It is important to take into account how the drug affects humans by
means of which processes are disrupted, which organs and tissues are targeted to anticipate
similar effects on nontarget organisms.
Taking into account the vague understanding of specific and nonspecific modes of action,
species differentiation, and nontarget organs and tissues affected, specific toxicity analysis is
difficult to perform and complicated to anticipate. Given what is known about the drugs through
experiment on humans, aquatic experimental outcomes should be targeted towards known target
4

modes of action based on the assumption of similar modes of action in different species and the
various side effects in humans. In order to evaluate which drug produced which result the current
study, like many other studies, was not performed in mixtures.
Importance of Study
Because these chemicals are environmentally present in small amounts it is only recently
that their existence has been proven. Analytical techniques and instrumentation able to detect
polar compounds at minute quantities have been particularly helpful to the advancement in
knowledge of environmental occurrence of pharmaceuticals (Fent et al. 2006). Minute amounts
of chemicals, typically considered safe because they occur at trace amounts, can elicit
unanticipated effects on ecosystems as evident by xenobiotics such as
dichlorodiphenyltrichloroethane (DDT) and polychlorinated biphenyls (PCBs) which have
hormone mimicking effects on the reproductive systems of organisms at nanograms per liter
(Colbum and Clement 1992).
It is important to identify and investigate potential environmental pollutants before
corrective measures are impossible. Since it is unlikely that people will be convinced to quit
taking pharmaceuticals what do needs to be executed? The primary studies on this subject must
start at the beginning. Hence the purpose of this study is to prove that there is a problem.
Environmental issues are typically excused until rehabilitation is almost irremediable brought to
light by some catastrophic event, usually mortality. Published literature is minute when you take
into consideration the large amount of APIs, metabolites, and other transformation products
developed and pumped into the environment, sublethal/lethal effects that may have not occurred,
the number of potential non-target organisms (Daughton et al. 1999).
The results from this study can help form databases in which other drugs with similar
modes of action or similar species to show effects (lethal and sublethal) and aid in future studies
5

to show what to look for. Often the type or magnitude of effects at lower concentrations is
predicted from the acute tests which incorporate larger doses.
Application of Results
Although they are exposed to low doses throughout their entire life, acute toxicity studies
which incorporate the large amounts needed to stimulate mortality are important to identify the
effects in worst case scenarios such as spills, wastewater treatment outflow, and if
pharmaceutical concentration increases due to bioaccumulation and the increase in potency.
Taking into account subtle or seemingly unimportant changes that could affect environment or
humans in the future could bring about changes in regulations, toxicity test practices, and public
awareness.
Simple observations during acute tests can aid in the analysis of environmental risk and
eventually aid in the development of new test regulations. It is probable that sublethal effects
could transpire from low concentrations. Although some effects may not be statistically
significant this does not lessen their importance.
Experimental ecotoxicological data for pharmaceuticals is scarce. Sanderson et al.
(2004) published ecotoxicological data for 2848 active pharmaceutical ingredients using
(Quantitative) Structure Activity Relationship ((Q)SAR). Environmental exposure is at least five
orders of magnitude less than LC50.
Ecological Structure Activity Relationships (ECOSAR) is a computerized program that
predicts the acute (short-term) toxicity and chronic (long-term or delayed) toxicity of chemicals
to aquatic organisms such as fish, aquatic invertebrates, and aquatic plants. ECOSAR uses
Structure Activity Relationships (SARs) to predict the aquatic toxicity of untested chemicals (i.e.
pharmaceuticals) regarding structural similarities of chemicals for which aquatic toxicity data are
available. The SARs in ECOSAR express correlations between a compound's physicochemical
6

properties and its aquatic toxicity within specific chemical classes. While many studies utilize
the program to predict the ecotoxicity of pharmaceuticals, it is important to note that the model
was created using industrial chemicals and the applicability of the models to predict effects of
pharmaceuticals should be carefully considered.
Maden et al. (2009) assessed the confidence in ECOSAR’s predictions. Several key
factors were considered during the ranking process: total number of classes into which
ECOSAR assigned the compound, presence of additional/unusual functionalities that could drive
or moderate the toxicity within a selected class, similarity to compounds in the ECOSAR
training set, overall size, and log Kow. The probability of the API falling within the relevant zone
of the class was classified by a numerical scale of 1-3. A confidence interval of 1 was given to
compounds likely to fall within the domain of the model; there was confidence that the SAR
prediction for the pharmaceutical was correct. A confidence interval of 3 was given to
compounds unlikely to fall within the domain of the model causing less confidence in the
prediction for the compound. Also given the number 3 were compounds ECOSAR allocated into
four, five, or six different classes lessening confidence in the correct assignment of class.
Because ethinyl estradiol fell into two ECOSAR classes (phenols and propargyl alchindered) and the molecule was different than those in the training set the assigned rank was 3
for phenols in all groups and propargyl alc-hindered class was ranked 3 for fish 96 hour LC50
and no predictions for daphnia 48 hour LC50 and algae 96 hour LC50. ECOSAR predicted a
higher potency in phenol class: fish 96 hour LC50, daphnia 48 hour LC50 and algae 96 hour
LC50 (Madden et al. 2009).
Fluoxetine was classified as aliphatic amine and given a rank of 3 for fish 96 hour LC50,
daphnia 48 hour LC50 and algae 96 hour LC50 signifying that it was unlikely that the API fell
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within the domain of the model and there was little confidence in the prediction of the compound
(Madden et al. 2009).
Objectives
The current single species study was designed to expose standard EPA organisms to six
concentrations of ethinyl estradiol and fluoxetine for 96 hours. Based on EPA’s 5th edition
(2002) acute static renewal test (EPA-821-R-02-012) test organisms (3 species of freshwater
organisms and 2 species of marine organisms) were exposed to six concentrations and a control
with four replications for 96 hours. A fifth replicate of concentrations void of organisms was
used for daily monitoring of water parameters. Median effective concentrations based on
lethality (EC50s) were quantified and the toxic responses were compared and contrasted.
Mortality was documented daily to assess time framed dose-responses for each test organism.
The highest test concentrations were chosen into order to induce at least 50% lethality (EC50).
Quantified 96 hour EC50s were established for five standard EPA test organisms determined
after test termination.
Because the environmental amounts are below those to stimulate mortality these results
of this study extend beyond lethality through the observation of sublethal effects which are not
required for acute test methods. In addition to high toxicity potential these two pharmaceuticals
are extremely potent in controlling hormonal, serotonergic, and dopaminergic systems in
mammals/humans which could interfere with key biological functions including but not limited
to fecundity, growth and development, and behavior in nontarget organisms. Organisms are
exposed for entire life cycles in environmental settings. In the current study juvenile organisms
were exposed during an important life stage of growth and development. Any changes could be
important to note because they were occurring within 96 hours.
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Hypothesis
1. Higher concentrations are expected to initiate lethality in at least half of the test
organisms. In the current study single species acute toxicity tests were conducted to document
and quantify mortality and to assess behavior after exposure to ethinyl estradiol, a synthetic
steroid present in most forms of birth control and fluoxetine, a selective serotonin reuptake
inhibitor used to treat depression. The higher concentrations are expected to initiate lethality in
EPA standard test organisms, Ceriodaphnia dubia (water flea), Daphnia pulex (water flea), and
Pimephales promelas (fathead minnow), which are freshwater species and Mysidopsis bahia
(mysid shrimp) and Menidia beryllina (inland silverside) which are marine organisms.
2. Similarly classified organisms are expected to generate comparable mortality data.
Mortality data is projected to be comparable to similarly classified organisms. For example,
water fleas and mysid should generate toxic responses similar to other crustaceans.
3. The lethal concentrations are expected to be smaller in simpler organisms and larger in
more complex organisms. The median lethal concentrations (EC50s) are expected to be smaller
in these simpler organisms with shorter life cycles, making them more susceptible and vulnerable
to contaminants. Because fish are more complex organisms with more intricate bodily functions
and longer life cycles they are expected to yield higher EC50s making them more resilient to
these drugs. The concentrations needed to induce mortality in these fish species should be
comparable to other fish species and higher than the amounts in crustaceans.
4. The lesser concentrations are likely to generate less lethality while diminishing
activity. It is probable that sublethal effects could transpire from lower concentrations.
Therefore, in addition to quantifying mortality, observations of behavioral changes were
recorded. It was expected that the lesser concentrations used in the present study were likely to
generate less lethality while diminishing normal activity.
9

Perspective of Planned Research
By proving the question that pharmaceuticals can affect organisms over short periods of
time, it can be argued that the problem will only increase because aquatic organisms are
environmentally susceptible to these chemicals throughout entire life cycles with multiple doses.
Bioconcentration and the addition of new pharmaceutical products on the market may
lead to higher concentrations of the compounds studied in the environment. The pharmaceutical
companies are producing more effective products for humans in order to perform their intended
action pharmaceutical companies by increasing potency, bioavailability, and degradation
resistance. This means more negative impacts for environment. Also because now our culture is
saying a pill can cure anything, the amounts used are increasing along with the human population
and availability of these drugs.

Also mixture effects are most often anticipated by the idea of

concentration addition in which the combined toxicity is derived from the addition of the
individual concentrations of each compound. With this said, in the current study, species
exhibited similar sublethal endpoints in both drugs. With this in mind, hypothetically
concentrations that do not illicit lethality can cause sublethal effects and based on additions can
occur at environmentally detected levels.
The environmental concentrations of EE2 and FLX could potentially increase due to the
exponential increase of the amounts being taken. Also these drugs are prescribed for long time
use with a large amount of the API excreted and entering the environment. The long half lives,
high resistance to degradation, high accumulation potential, and high water solubility allow these
chemicals to persist in the environment. Moreover, the pharmaceutical industry is producing
more effective active APIs by increasing potency, bioavailability, and degradation resistance.
These oppositions increase the potential for these compounds to remain in animal tissue and
bioaccumulate enforcing biomagnifications and bioconcentrations.
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This study covers a spectrum of aquatic organisms (simple and complex) and their food
source to help demonstrate what can happen if an organism is affected and thus the food chain
which may intern affect humans. There is the cases in which physiological differentiation can
play a role (i.e. aquatic organisms will react differently than mammals). More complex
organisms that are distressed at higher concentrations can be affected at lower levels of
contamination in the sense that their food source is simpler and will be stressed at lower
concentrations. The current study included quantified effects of simple and complex organisms
to aid in investigating aquatic ecosystems as a whole. Changes at any level of the food chains
will upset environmental balance. Previously documented tests do not incorporate effects of
food sources nor do they take into account how these changes affect the test organism. The
existence of these studies demonstrates that a problem can occur but by the time the public
realizes it may be too late.
In addition to quantified EC50s, concentration boundaries were noted for sublethal
effects observed during the test. The organisms were exposed to high concentrations during
sensitive life stages which could aid in understanding how they affect nontarget organisms,
anticipating effects for future studies, and/or risk assessment at environmentally detected
concentrations.
It is the unpredicted effects that are causing harm to ecosystems. Abnormalities have a
number of possible explanations or in some cases, cannot be explained. A major concern is the
effects which are barely noticeable but accumulate over time to yield extreme changes masked
by time and perhaps not distinguishable from natural events. Even subtle alterations in normal
life progressions control the promise to directly or indirectly affect entire species populations.
Any degree of disturbance of the environmental balance can bring about catastrophes leading to
deteriorations of entire ecosystems.
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LITERATURE REVIEW
Pharmaceutical Industry
Pharmaceutical chemicals are defined as prescribed and nonprescribed ―intended to affect
the structure or any function of the body of man or other animals.‖ These substances are
responsible for physiological or pharmacological action used to prevent, diagnose, cure, treat, or
mitigate diseases (The Food, Drug and Cosmetic (FD&C) Act, sec. 201(g) (1)). Pharmaceuticals
can serve as preventatives to disease and disability (e.g. lipid-lowering drugs that lessen the risk
of coronary artery disease) and aid in the management of the body’s self-regulating systems (e.g.
high blood pressure and thyroid drugs) in which they can replace or supplement needed
chemicals (e.g. insulin and vitamins). They can cure some diseases (e.g. antibiotics), serve as
new treatments where previously there were none (e.g. drugs for HIV), control symptoms (e.g.
analgesics or pain relievers and asthma drugs), or can serve as complements to medical
procedures (e.g. anticoagulants during heart valve replacement surgery) (Berndt 2001; Chockley
2001).
There are numerous groups of pharmaceuticals including but not limited to human and
veterinary medicinal compounds; nutraceuticals, which are bioactive food supplements; and the
classic small molecule drugs which are manufactured primarily through organic synthesis and
biotech drugs. At the end of 2009, the Food and Drug Administration had approved more than
1,350 small molecule drugs, 123 biotech drugs (protein/peptide), 71 nutraceuticals and more than
3,243 experimental drugs (Hazardous Substances Databank 2009). Every year thousands of tons
of drugs are utilized to treat illnesses, to prevent unwanted pregnancy, or to face the stresses of
modern life (National Center for Health Statistics 2004).
The per capita consumption of pharmaceutical drugs is steadily increasing because of
expiration of patents resulting in availability of less expensive generics and the discovery of new
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uses for existing drugs. Between 1988 and 1994, 39% of Americans were using at least one
prescription drug and 12% of Americans were using at least three prescription drugs. In 2005,
the percentage of Americans using one prescription increased to 44%, and 17% were using at
least three prescription drugs (National Center for Health Statistics 2004).
North America represents about half of global pharmaceutical sales. Pharmaceutical sales
in the United States increased from $152.8 billion in 2000 to $248 billion in 2004. This
dominant market is expected to reach $330 billion by the year 2010 with an estimated annual
growth rate of 8.5%. The exponential increase in pharmaceutical consumption is correlated with
increasing population, advancing medical technology and research, increasing life span
expectancy, and escalating health care spending (Khetan and Collins 2007).
Pharmaceutical sales in North America have been rising nearly seven times faster than
the expanding population growth rate (Khetan and Collins 2007) which has risen an average
annual growth rate of 1.2% (National Center for Health Statistics 2006). In 2006, the U.S.
population was 300 million compared to 151 million in 1950 (National Center for Health
Statistics 2004).
An inverted age structure in the general population and a rise of new target age groups
are major contributors to this market increase (Daughton 2003; Khetan and Collins 2007).
Because of chronic disorders, older people are more likely to take more pharmaceuticals than
younger individuals and have typically been targeted by marketing companies (Beers 2003).
However, marketing strategies now encompass all age groups by emphasizing the idea that a pill
can cure anything and increase life expectancy. However, patents are expiring allowing generics
to become available at a lower cost making them more available to the public (Khetan and
Collins 2007).
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Two of the most popular pharmaceuticals in the United States have been available for
decades. The Federal Drug Administration approved the use of the synthetic estrogen ethinyl
estradiol in June 1943 for birth control or hormone treatment, and the Selective Serotonin
Reuptake Inhibitor, fluoxetine in December 1987 as an antidepressant (Food and Drug
Administration). Ethinyl estradiol ranked 8th and fluoxetine ranked 13th based on the number of
prescriptions dispensed in 2004 in the United States (The Internet Drug Index 2010).
Ethinyl Estradiol Mechanics
The most frequent uses of ethinyl estradiol, a synthetic form of estrogen, are as combination
oral contraceptive or hormone replacement therapy in postmenopausal women (Hardman 1996).
It is applicable in the treatment of:
 menopausal and post menopausal symptoms
 moderate to severe vasomotor symptoms (International Agency for Research on Cancer
1999; United States Pharmacopeia Drug Information 1999)
 malignant neoplasm of the breast and prostate (International Agency for Research on
Cancer 1999)
 metastatic breast carcinoma in selected men and postmenopausal or oophorectomized
women
 female hypogonadism, primary ovarian failure, or ovariectomy
 advanced prostatic carcinoma (United States Pharmacopeia Drug Information 1999)
 Turner's syndrome
 acne in women
 athletic functioning as an enrichment supplement and veterinary supplements (Daughton
and Ternes 1999)
Ethinyl estradiol is prepared from natural estrogen (United States Pharmacopeia Drug
Information (USPDI) 1999). Desirable therapeutic actions on the female reproductive tract
involve stimulation of proliferation and differentiation in the fallopian tube, an increase of the
tubal muscular activity, an increase of the water content of cervical mucus, and support in
contraction of the uterine myometrium. Estrogens increase the synthesis of DNA, RNA, and
various proteins in target tissues. Estrogens reduce the release of gonadotropin-releasing
hormone from the hypothalamus, leading to a reduction in release of follicle-stimulating
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hormone and luteinizing hormone from the pituitary while the pituitary mass is increased
(USPDI 1999).
Ethinyl estradiol is rapidly and completely absorbed from the gastrointestinal tract (USPDI
1999). This lipophilic synthetic steroid diffuses readily through cellular membranes to bind to
estrogen receptors in the nucleus in order to regulate gene expression by increasing or decreasing
the transcription of hormone regulated genes depending on the tissue receptor which is activated.
Ethinyl estradiol activates the estrogenic receptor and regulates gene expression in the female
reproductive tract, pituitary, hypothalamus, bone, liver, and other tissues (Hazardous Substances
Databank).Receptor activation differs upon which targets are affected (USPDI 1999). The
reported bioavailability of circulating EE2 is 40% almost fully bound to plasma albumin. Oral
ingestion results in peak plasma concentrations 2-3 hours later with a 12 hour peak thought to
represent extensive enterohepatic circulation (USPDI 1999). Unbound molecules are widely
distributed to most tissues, especially breast, uterine, vaginal, hypothalamic, and pituitary tissues;
with a high affinity for adipose tissue (USPDI 1999). Metabolism involves hydroxylation of the
aromatic ring in the liver by the cytochrome P450 3A4 isoenzyme after it is absorbed by the
small intestine. Metabolism is slow compared to estrogen. The ethinyl substitution (C-triple
bond-CH group) in the C17 position inhibits first-pass metabolism (USPDI 1999). Primary route
of biotransformation is through 2-hydroxylation and the formation of 2- and 3-methyl ethers
(USPDI 1999).
Following a single oral therapeutic dose biological half life is approximately 7.7 hours
(USPDI 1999). The elimination phase half-life has been reported to be 13 to 27 hours (Hardman
et al. 1996). In contrast to the metabolites of natural estrogen, a significant proportion of the
metabolites of ethinyl estradiol in humans are excreted by the fecal route; ethinyl estradiol itself
is excreted in urine and feces in a ratio of about 4:6. About 90% of the metabolites from ethinyl
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estradiol are recovered in both feces and urine (International Agency for Research on Cancer
1999). Excretion is via feces due to some enterohepatic circulation of sulfate and glucuronide
metabolites; excretion is also via the kidneys (Hazardous Substances Databank 2009). Excretion
is mainly through urine; however, the enterohepatic circulation of the sulfate and glucuronide
metabolites allows it to also be excreted in feces (Hazardous Substances Databank 2009). The
metabolites glucuronide and sulfate conjugate as well as the unabsorbed portion are excreted as
both urine and feces.
Fluoxetine Mechanics
Fluoxetine is classified as an antidepressant for the treatment of major depressive
disorder and to relieve the symptoms of premenstrual dysphoric disorder (PMDD). Acute
depressive episodes typically require 6-12 months of antidepressant therapy while chronic
depression may require long-term treatment. Fluoxetine is also used in the treatment of:
 obsessions and compulsions in patients with obsessive-compulsive disorder
 binge-eating and vomiting behaviors in patients with moderate to severe bulimia nervosa
(United States Pharmacopeia Drug Information (USPDI) 2003; O'Neil 2001)
 short term management of exogenous obesity for a limited number of patients (McEvoy
2003)
The precise mechanism of antidepressant action of fluoxetine is unclear, but the drug has
been shown to selectively inhibit the reuptake of serotonin (5-HT) at the presynaptic neuronal
membrane (McEvoy 2003). Fluoxetine, like most Selective Serotonin Reuptake Inhibitors,
hinders the 5-hydroxytryptamine transporter (5-HTT), a serotonin transporter in the central
nervous system (Kreke and Dietrich 2008). Thus this inhibition increases the concentration of
serotonin and reinforces serotonergic neuronal transmission. Fluoxetine specifically inhibits
central nervous system (CNS) neuronal re-uptake of serotonin, thus increasing the concentration
of the serotonin at the synapse and reinforcing of serotonergic neuronal transmission. Fluoxetine
has little effect on other neurotransmitters and may interact with other drugs or circumstances
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which cause serotonin release (International Programme on Chemical Safety (IPCH) 1999).
Fluoxetine-induced inhibition of serotonin reuptake causes increased synaptic concentrations of
serotonin in the CNS, resulting in numerous functional changes associated with enhanced
serotonergic neurotransmission (McEvoy 2003). The enhancement of the serotonergic effects
may produce a life-threatening serotonin syndrome (USPDI 2003).
Most SSRIs only increase the amount of serotonin. Fluoxetine increased extracellular
concentrations of serotonin, norepinephrine and dopamine after acute dosing. The concentration
of monoamines was sufficient in blocking 5-HT receptors accounting for the increase of
catecholamines (Bymaster et al. 2002).
Fluoxetine hydrochloride administered orally is readily absorbed from the gastrointestinal
tract with peak plasma concentrations appearing from 6 to 8 hours later. The systemic
bioavailability is greater than 85% and does not appear to be affected by food with plasma
protein binding at 94% (IPCH 1999).
Fluoxetine is widely distributed throughout the body with highest concentrations
occurring in the lungs and liver; however, distribution of fluoxetine and its metabolites into
human body tissues and fluids has not been fully characterized (USPDI 2003). It is known that
fluoxetine and norfluoxetine cross the blood-brain barrier in humans and animals one hour after
administration with concentrations present in the cerebral cortex, corpus striatum, hippocampus,
hypothalamus, brain stem, and cerebellum (McEvoy 2003).
When metabolized, fluoxetine undergoes N-demethylation catalyzed by the cytochrome
P-450 isoenzyme CYP2D622 in the liver which produces the metabolite norfluoxetine which is
just as active as the parent compound. Fluoxetine is metabolized to norfluoxetine, a desmethyl
active metabolite similar to FLX, by the liver with peak plasma concentrations occurring 76
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hours after dosing (USPDI 2003). Under normal conditions, the concentration of the metabolite
is greater than the parent compound (Hiemke and Härtter 2000).
The long and highly variable half-life of FLX ranges from 1 to 4 days after a single dose
with an average of nearly 70 hours. However, after receiving high doses over long periods of
time prolonged elimination half-lives may occur. Norfluoxetine has a half-life of about 7 to 9
days (IPCH 1999). The primary hypothesized primary route of elimination is further hepatic
metabolism to inactive metabolites which are conjugated and then excreted in the urine
(Hemeryck and Belpaire 2002). Less than 10% unchanged parent compound is primarily
excreted in urine (Hiemke and Härtter 2000).
Entrance into the Environment
Active pharmaceutical ingredients (APIs) enter the environment through a variety of
pathways. The major pathway is through WWT facility effluent. Unmetabolized portions or
active metabolites that are not absorbed are secreted in urine or feces and then emitted into raw
sewage (Halling-Sorensen et al. 1998; Daughton et al. 1999). Flushing unused medications is a
minor pathway which appears to be of lesser importance than the primary pathway of excretion
(Heberer 2002). Unused or expired pharmaceuticals are often flushed thus contributing to the
environmental pollution (Halling-Sorensen et al. 1998). Drugs administered close to the end of
one’s life can leach from cemeteries and into groundwater (Daughton 2003). Pharmaceuticals
may enter the environment through drug-containing waste from manufacturing facilities
(Daughton and Ternes 1999).
After oral administration pharmaceuticals can either be fully or partially absorbed from the
gastrointestinal tract and then degraded by metabolic processes. After the drug is metabolized by
the body it is only slightly changed. These by products are often times conjugated to polar
molecules such as glucoronides. Metabolism of the drug may occur to a large or small extent.
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Excreted materials may include the metabolites, the parent molecule, or a mixture of both
and are then released into the environment via wastewater effluent (Jones et al. 2001; Kummerer
and Giampaolo 2006). Most medical substances are metabolized to phase I or phase II
metabolites before being excreted from the body with the urine and might arrive in the
environment as such. Metabolic Phase I reactions usually consist of oxidation, reduction or
hydrolysis, and the products are often more reactive, and sometimes more toxic, than the parent
compound. Metabolic phase II reactions involve conjugation, which normally results in inactive
water soluble compounds. Both phase I and phase II reactions change the physiochemical
properties of the substance because biotransformation produces metabolites that are more water
soluble than the parent compound. Thus, often it is not only the parent compound which should
be the subject of risk assessment but also the primary metabolites.
Parent compound  into more water soluble phase I metabolites
Parent compound  into more water soluble phase II metabolites
Phase I metabolite  into more water soluble phase II metabolite
Phase II metabolites  into less water soluble parent compound or phase I metabolite
(Halling-Sorensen et al. 1998).
Wastewater treatment plants do not degrade all of the fractions of original pharmaceutical
products. Bacteria in the wastewater treatment process cleave these conjugate groups and the
metabolites are restored to the parent compound (Heberer 2002; Halford 2008). These products
enter the environment via treated or untreated raw sewage (Halling-Sorensen et al. 1998;
Daughton et al. 1999; Ternes, 1998; Zuccato et al. 2000; Kummerer 2004; Halford 2008).
Sewage systems are not equipped for removal of pharmaceuticals and personal care products
(PPCPs). Currently, there are no wastewater treatment facilities that are engineered to remove
pharmaceuticals or other unregulated contaminants such as personal care products. Effective
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removal of these unregulated chemicals can differ depending on the properties of the chemical
and on the individual sewage treatment facilities (USEPA 2010). The high polarity and low
volatility of most pharmaceutical means that they are likely to be transported to the water
compartment (Breton and Boxall 2003).
Wastewater is often reused for drinking water which can increase the risk of
pharmaceuticals reentering the human body as either the parent molecule or a transformed
molecule (Khetan and Collins 2007). Most drinking water treatment plants first add coagulant
salts and polymers to destabilize colloidal particles. Then the coagulated water is agitated to
promote the aggregation of suspended materials. Finally, water is stilled into order to settle
suspended solids and floccules for removal. This process, known as coagulation-flocculationsedimentation (C-F-S), is followed up by chlorination. However, due to the polarity of most
pharmaceuticals, they are not typically removed by the C-F-S process (Khetan and Collins
2007).
Leaching into groundwater can occur thus contaminating a potential drinking water
supply. Pharmaceuticals are not significantly absorbed in the subsoil due to their polar structure
(Khetan and Collins 2007). Sewage treatment plants with longer solids retention times will
remove more pharmaceuticals and other chemicals. The sorption coefficients (log Koc) to
dissolved organic matter was 4.72 and for a model sediment of Elliott Silt Loam soil was 4.87
(Yammomoto et al. 2005). Log Koc for FLX is 0.64, 0.97, and 3.70 at the pH 2, 7, and 11
respectively (Brooks et al 2003a).
Historical Background
One of the first concerns of pharmaceuticals adversely affecting the environment was
presented by a study investigating the biotransformation of estrogenic hormones by activated
sludge which could impact the ecosystem (Stumm-Zollinger and Fair 1965; Tabak and Bunch
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1970). In 1976 drugs were detected in sewage at the Big Blue River sewage treatment plant in
Kansas City (Hignite and Azarnoff 1977). The first reported occurrence of pharmaceuticals in
USA treated wastewater was 8 x 10-1 – 2 ppb of clofibric acid (Garrison et al. 1976). The most
severe example of pharmaceutical contamination has been the feminizing of aquatic species to
estrogenic compounds. In the mid-1980s fish living in sewage treatment lagoons exhibited
feminization (Daughton et al. 1999). In the 1990s, scientists observed that male fish living
downstream of WWTP began conceiving early-stage eggs in their testes and producing proteins
associated with egg production typically occurring in female fish. Feminized male fish have
been reported in rivers and streams in the U.S. and Europe (Halford 2008).
Behavior in the Aquatic Environment
Pharmaceuticals and personal care products are continuously released into the
environment. Ecosystems at maximum risks do not have upstream dilution (Brooks et al. 2003b).
Active pharmaceutical ingredients (APIs) that may undergo environmental transformation by
means of degradation or dilution can be offset by replacement discharges (Daughton et al. 1999).
The behavior and fate of APIs and associated metabolites in the aquatic environment are
not completely understood. Low volatility denotes dispersal through aqueous transport with the
possibility of food chain distribution (Fent et al. 2006). The maximum solubilities in water have
been established for EE2 (1 x 10-2 ppb) (Yalkowsky and Dannenfelser 1992) and for FLX (1 x
10-5 ppb (mg/mL)) (O'Neil 2001).
The operation of pharmaceuticals in surface waters is dependent on temperature and light
intensity. Low temperatures and shorter daylight hours typical of winter months may lead to
decreased biodegradation and decreased photodegradation of chemicals. Surface waters that are
prone to snow and ice are less likely to break down pharmaceuticals. In summer months,
characterized by higher temperature and high levels of light, chemicals may become less potent
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(Khetan and Collins 2007). Metabolites can be transformed to their parent molecule through
waste water treatment (WWT) processes or environmental conversions.
The higher the log Kow (octanol-water coefficient) the more hydrophobic the compound
is and the greater probability for bioaccumulation. Lipophilic xenobiotics (log Kow >3) are likely
to enter fish bloodstreams primarily across the gills (Kreke and Dietrich 2008).The reported log
Kow (octanol-water coefficient) for EE2 is 3.67 (Hansch et al. 1995) with a predicted log Kow of
4.12 by ECOSAR (Sanderson et al. 2004). The reported log Kow for FLX is 1.0, 1.8, and 2.6 at
pH 5, 7, 9 respectively (Eli Lilly and Company 2005) and 1.25, 1.57, and 4.30 at pH 2, 7, and 11
respectively (Brooks et al 2003a). The predicted log Kow by ECOSAR was 4.65 (Sanderson et al.
2004).
Bioaccumulation. Upon entering the environment, the potential for bioaccumulation in
food chains occurs (Kummerer and Giampaolo 2006). The pharmaceutical industry is producing
more effective active pharmaceutical ingredients (APIs) by increasing potency, bioavailability,
and degradation resistance (Khetan and Collins 2007). In order for pharmaceuticals to perform
their intended action, they are resistant to biodegradation. However this opposition to
biodegradation increases the chances that these drugs bioconcentrate and biomagnify. These
drugs may remain in animal tissue and bioaccumulate enforcing biomagnifications (Carbonell et
al. 2000).
Increase in accumulation of EE2 based on whole body residue of F1 generation
Pimephales promelas (fathead minnow) embryos less than24 hours post fertilization (hpf)
exposed to 5 x 10-2 ppb EE2 had a bioconcentration factor (BCF) of 660. Those exposed to 2 x
10-4 ppb had a BCF less than 2400. The concentration 8 x 10-4 ppb yielded a BCF less than 500.
Organisms exposed to 1 x 10-2 ppb had a BCF of 610 (Lange et al. 2001). An increase in
elimination of EE2 was found in adult Oncorhynchus mykiss (rainbow trout) exposed for 0-50
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days to 1 x 10-3 – 1 ppb based on residue in plasma of (Schultz et al. 2001). Juvenile Acipenser
fulvescens (lake sturgeon) showed an increase in accumulation of residue in plasma at 6 x 10-2
ppb with no effect at 1 x 10-2 ppb (Palace et al. 2001).
Lepomis macrochirus (bluegill), Ictalurus punctatus (channel catfish), and Pomoxis
nigromaculatus (black crappie) sampled from 100 meters downstream from the effluent
discharge in Pecan Creek and L. macrochirus and Cyprinus carpio (carp) in Clear Creek had
levels of fluoxetine in the brain. These fish species studied from two streams in Denton County,
Texas, USA represent a bioaccumulation effect. However, the effects of 2 ppb FLX on the
nervous system of fish have not yet been investigated (Brooks et al. 2005).
Oryzias latipes (Japanese medaka) were exposed to fluoxetine at a nominal concentration
of 6 x 10-1 ppb for 7 days and subsequently allowed to depurate in clean water over a 21 day
period. Fluoxetine uptake by medaka was observed within the first 5 hours of exposure and the
biologically active metabolite, norfluoxetine, was also detected in medaka tissues during this
timeframe. Maximum FLX concentration was measured in medaka by the third day of the uptake
phase, yielding an uptake rate constant (k1) of 5.9 ± 0.5 per day. During the depuration phase of
the experiment, a half life of 9.4 ± 1.1 days was determined for fluoxetine. Using these data,
bioconcentration factor (BCF) values of 74 and 80 were estimated for fluoxetine and a pseudoBCF (the ratio of the concentration of norfluoxetine in medaka and the aqueous fluoxetine
concentration) of 117 was calculated for norfluoxetine. These results indicate longer persistence
and greater potential for the bioaccumulation of fluoxetine and norfluoxetine in fish tissues than
would be predicted from prior half life estimates derived using mammalian species (Paterson and
Metcalfe 2008).
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Environmental Concentrations
Persons prescribed these drugs take them for many months, usually years. These
medications are recommended for long term treatment which results in continuous pollution into
environment. Although pharmaceuticals have been present as long as humans have been taking
them, it is through recent advancements in analytical instrumentation and techniques that their
presence in the environment has been proven because they typically exist in nanograms per liter
(Halford 2008). Analytical techniques and instrumentation able to detect minute quantities of
polar compounds have been particularly helpful to the advancement in knowledge of
environmental occurrence of pharmaceuticals (Fent et al. 2006).
Minute environmental concentrations of ethinyl estradiol have been detected in different
media including but not limited to: surface water (less than 2 x10-4 parts per billion (μg/L)),
effluent from sedimentation tank (3-5 x10-4 ppb), river water (2 - 15 x10-3 ppb), reservoir (1 - 3
x10-3 ppb) and drinking water (less than 5 x10-3 ppb) (Halling-Sørensen et al. 1998). The
influent (3 x10-3 ppb) and effluent (4 x10-4 ppb) of a wastewater treatment facility reached 85%
maximum removal by activated sludge (Baronti et al. 2000).
Fluoxetine has been detected in the following media: municipal wastewaters (5 x10-2
ppb) (Gange et al. 2006), reclaimed water facility effluent (5 x 10-3 ppb) (Kinney et al. 2006),
waste water treatment plant effluent in Calgary, CA (5 x 10-2 ppb) (Chen et al. 2006), and stream
waters (1 x 10-1 ppb) (Metcalfe et al. 2003b). Weston et al. (2001) detected 5 x 10-2 ppb of FLX
in WWT effluent with 79-82% recovery; however, with 67-77% recoveries for norfluoxetine, the
metabolite was not detected. Using isotope dilution liquid chromatography/tandem mass
spectrometry the amounts of fluoxetine and norfluoxetine were analyzed from a number sewage
treatment plant (STP) influents, effluents, and drinking water reservoirs. The detected amounts
of FLX were 2 x 10-2 ppb in the influent, 3 x 10-2 ppb in the effluent, 3 x10-3 ppb in the drinking
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water. Norfluoxetine was detected in the influent at 1 x 10-2 ppb, in the effluent at 4 x 10-3 ppb,
and in the drinking water at 1 x10-3 ppb (Vanderford and Snyder 2006).
In 2002 the United States Geological Survey (USGS) performed a national survey in
which pharmaceuticals and personal care products (PPCPs) were detected in 139 rivers in 30
states. A plethora of biologically active compounds were detected in 80% of these populated and
remote locations with an average recovery of about 60%. Antibiotics and hormones were found
with the greatest frequency in North American waterways. Other detected pharmaceuticals
included contraceptives, painkillers, anticancer drugs, blood-pressure medications,
antidepressants, and drugs used to treat epilepsy. Ethinyl estradiol occurred with a frequency of
16% with an estimated maximum of 8 x 10-1 ppb and an estimated median detectable
concentration of 7 x 10-2 ppb. Fluoxetine occurred with a frequency of 1% with an estimated
maximum and median detectable level of 1 x10-2 ppb. When compared to other man-made
pollutants, pharmaceuticals represent a minute portion of environmental pollutants (Halford
2008).
Although the concentrations of some of these drugs may be considered small, these drugs
were designed to have a profound effect at low concentrations (Koplin et al. 2002). It is
estimated that pharmaceuticals are environmentally present at concentrations below those needed
to cause considerable harm. It would rash to assume that these compounds were not affecting
the ecosystems until there is irrefutable evidence to suggest otherwise (Jones et al. 2004).
Studies have shown that concentrations of EE2 and FLX, many above the environmental
detected levels, can stimulate health effects and lethality in animals and some plants (Jones et al.
2004).
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Lethal Effects of Ethinyl Estradiol
Ethinyl estradiol produced LC50s for numerous organisms (Table 1). Gammarus pulex
(scud), when exposed to EE2, had a 72 hour LC50 between 2 x 103 ppb - 4 x 103 ppb. The
mortality increased from day 5-9 but the LC50 remained 0 - 2 x 103 ppb. The 10 day LC50 was
8 x 102 ppb (Watts et al. 2001). The Tisbe battagliai (harpacticoid copepod) had a 10 day and 21
day LC50 greater than or equal to 1 x 102 ppb based on mortality (Hutchinson et al. 1999).
Pounds et al. (2002) found the same LC50s based on survivorship.
Table 1. Exposure times and concentrations of ethinyl estradiol reported to provoke 50%
lethality (LC50S) in aquatic organisms.
Exposure
Organism
Dose
Trend/Response
Reference
Time
(ppb)
24 hours
48 hours
48 hours
72 hours
96 hours
96 hours
96 hours
96 hours
5-9 days
10 days
10 days
21 days
10 days
21 days

Gammarus pulex
(Scud)
Acartia tonsa
(Calanoid Copepod)
Gammarus pulex
(Scud)
Gammarus pulex
(Scud)
Gammarus pulex
(Scud)
Neomysis integer
(Opossum Shrimp)
Nitocra spinipes
(Harpacticoid Copepod)
Danio rerio
(Zebrafish)
Gammarus pulex
(Scud)
Gammarus pulex
(Scud)
Tisbe battagliai
(Harpacticoid Copepod)
Tisbe battagliai
(Harpacticoid Copepod)

8 x 103

Increase in Mortality

Watts et al. 2001

1 x 103

Increase in Mortality

Andersen et al. 2001

4 x 103

Increase in Mortality

Watts et al. 2001

> 2 x 103
< 4 x 103

Increase in Mortality

Watts et al. 2001

2 x 103

Increase in Mortality

Watts et al. 2001

1 x 103

Increase in Mortality

Verslycke et al. 2004

5 x 102

Increase in Mortality

Breitholtz and
Bengtsson 2001

2 x 103

Mortality

Versonnen et al. 2003

>0
< 2 x 103

Increase in Mortality

Watts et al. 2001

8 x 102

Increase in Mortality

Watts et al. 2001

≥ 1 x 102

Increase in Mortality

Hutchinson et al.1999

≥ 1 x 102

Decrease in Survival

Pounds et al. 2002

Generally exposure to ethinyl estradiol caused a decrease in hatchability (Table 2).
Hatchability for Danio rerio (zebrafish) embryos 4-6 hours old with hatch times documented on
days 1, 26, and 30 resulted in a 74 hour ET50 of 1 x 10-3 ppb and 3 x 10-3ppb, and a 75 hour
ET50 of 8 x 10-3 ppb (Bogers et al. 2006). The decrease in hatchability of Pimephales promelas
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(fathead minnow) exposed for 1 day post hatch caused an NOEC greater than or equal to 5 x 10-2
ppb and an LOEC greater than 5 x 10-2 ppb (Lange et al. 2001).
Table 2. Exposure times and concentrations of ethinyl estradiol reported to provoke the
endpoints associated with hatchability of aquatic organisms.
Organism
Response Exposu
End
Dose
Trend
Reference
re Time
Point
(ppb)
Danio rerio
(Zebrafish)

Hatchability

Danio rerio
(Zebrafish)

Hatchability

Pimephales promelas
(Fathead Minnow)

Hatchability

74 hours

ET50

75 hours

ET50
NOEC
LOEC

1 x 10-3
3 x 10-3
8 x 10-3
1 x 10-3
1 x 10-2

NOEC

≥ 5 x 10-2

LOEC

-2

58 days
1 dph

> 5 x 10

Bogers et al.
2006
Hill and Janz
2003
Decrease

Lange et al.
2001

Generally exposure to ethinyl estradiol caused a decrease in survivorship (Table 3). A
study supplying F0 generation Cyprinodon variegates (sheepshead minnow) with 2 x 10-4, 2 x
10-3, and 2 x 10-2 ppb resulted in no toxicopathic stress; endurance was similar to controls.
Survival was significantly reduced in subadults after 73 days in 4 x 10-1, 8 x 10-1, 2, and 3 ppb
producing: an NOEC of 1 x 10-1 ppb and an LOEC of 3 x 10-1 ppb, and an MATC of 2 x 10-1
ppb. F1 generation embryos retained a decrease in survivorship after 73 days, ensuing an NOEC
of 9 x 10-2 – 1 x 10-1 ppb, an LOEC of 3 x 10-1 – 4 x 10-1 ppb, and an MATC of 3 x 10-1 ppb
(Zillioux et al. 2001). Tisbe battagliai (harpacticoid copepod) less than24 hours old exhibited
decreased survivorship launching 10 and 21 day NOECs greater than or equal to 1 x 102 ppb and
LOECs greater than 1 x 102 ppb (Pounds et al. 2002). Hutchinson et al. (1999) found the same
endpoints with a decrease in survivorship for the NOEC but found an increase in survivorship for
the LOEC. Based on decreased survivorship in Danio rerio (zebrafish) embryos after hatching
the 1 day NOEC was 8 x 10-3 ppb. An increase in survivorship was noted on days 26 and 30
yielding an NOEC of 8 x 10-3 ppb (Bogers et al. 2006). Pimephales promelas (fathead minnow)
embryos less than 24 hpf exposed for 28 days post hatch manifested diminished survivorship

27

yielding an NOEC of 1 x 10-2 ppb and an LOEC of 5 x 10-2 ppb. Dosing for 56 days post hatch
provoked an NOEC of 1 x 10-2 ppb with 22.99 – 23% mortality and an LOEC of 5 x 10-2 ppb
with 25-31% mortality. At 176-301 days post hatch an NOEC for survivorship was greater than
or equal to 8 x 10-4 ppb with an LOEC greater than 8 x 10-4 ppb (Lange et al. 2001).
Table 3. Exposure times and concentrations of ethinyl estradiol reported to provoke the
endpoints associated with survivorship of aquatic organisms.
Organism
Response
End
Dose
Trend
Exposure
Reference
Point
(ppb)
Time
Hyalella azteca
(Scud)
Tisbe battagliai
(Harpacticoid
Copepod)
Tisbe battagliai
(Harpacticoid
Copepod)
Cyprinodon
variegates
(Sheepshead
Minnow)

Survivorship
Survivorship

Survivorship

Survivorship

Survivorship

Danio rerio
(Zebrafish)

Survivorship

Oncorhynchus
tshawytscha
(Chinhook
Salmon)
Pimephales
promelas
(Fathead Minnow)
Pimephales
promelas
(Fathead Minnow)
Pimephales
promelas
(Fathead Minnow)
Tilapia aurea
(Tilapia)

1 x 102

NOEC

≥ 1 x 102

Decrease

LOEC

2

Increase

NOEC

Survivorship
Survivorship

Decrease

10 and 21 days

Pounds et al.
2002

2

NOEC

1 x 10-1

LOEC
MATC

MATC

3 x 10-1
2 x 10-1
9 x10-2 –
1 x 10-1
3 x 10-1 –
4 x 10-1
3 x 10-1

NOEC

8 x 10-3

Decrease
Increase

1 day
26 and 30 days

Bogers et al.
2006

4 x 102

Decrease

194 dph

Piferrer and
Donaldson 1992

LOEC

NOEC
LOEC
NOEC

Survivorship

≥ 1 x 102

Hutchinson et
al. 1999

> 1 x 10

Survivorship

Survivorship

> 1 x 10

10 and 21 days

LOEC

NOEC

Cyprinodon
variegates
(Sheepshead
Minnow)

Vandenbergh
2003

LOEL

73 days

73 days

Decrease
5 x 10-2
1 x 10-2
5 x 10-2

NOEC

≥ 8 x 10-4

LOEC

> 8 x 10

-4

NOEL

2 x 105

Zillioux et al.
2001

Decrease

1 x 10-2

LOEC

Zillioux et al.
2001

Decrease

28 dph

Lange et al.
2001

56 dph

Lange et al.
2001

176-301 dph

Lange et al.
2001

40 days

Melard 1995

Decrease

Decrease

Generally, exposure to EE2 increased mortality in aquatic organisms (Table 4). Clutch
Danio rerio (zebrafish) exhibited a decrease in hatchability resulting in a 58 day NOEC of 1 x
28

10-1 ppb and an LOEC of 1 x 10-2 ppb (Hill and Janz 2003). Danio rerio (zebrafish) encountered
mortality at 25 (46%), 30 (53%), 40 (53%), and 60 (53-54% mortality) days post hatch. For all
days post hatch, the reported NOEL was 2 x 10-2 ppb. The LOEL for 20 days post hatch was 2 x
10-2 ppb (Andersen et al. 2003). Danio rerio (zebrafish) frys 2 dph had mortality after exposure
for 58 days yielding an NOEC of 100 E-4 ppb and an LOEC of 1 x 10-1 ppb (Hill and Janz
2003). Pimephales promelas (fathead minnow) displayed an increase in mortality on days 013.3 in 5 x 10-2 ppb; however, a decrease in mortality was observed on day 21 in 1 x 10-2 ppb
(Lange et al. 2003).
Table 4. Exposure times and concentrations of ethinyl estradiol reported to provoke the
endpoints associated with mortality of aquatic organisms.
Organism
Response
End
Dose
Trend
Exposure
Reference
Point
(ppb)
Time
Danio rerio
(Zebrafish)

Mortality

Danio rerio
(Zebrafish)

Mortality

Danio rerio
(Zebrafish)

Mortality

Danio rerio
(Zebrafish)
Danio rerio
(Zebrafish)

NOEL

2 x 10-2

LOEL

2 x 10-2
5 x 10-3
–
5x 10-2
3 x 10-4
–
9 x10-2

10 dph
25 dph
30 dph
40 dph
60 dph
20 dph

Anderson et al.
2003

Increase

0-21 days

Van den Belt et
al. 2001

Increase

21 days

Islinger et al.
2003

Mortality

NOEL

1

33 days

Mortality

NOEL

1 x 10-2

58 days

Danio rerio
(Zebrafish)

Mortality

LOEL

5

Danio rerio
(Zebrafish)

Mortality

NOEC
LOEC

5 x 10-3
5 x 10-2

Danio rerio
(Zebrafish)

Mortality

NOEC

3 x 10-2

Danio rerio
(Zebrafish)

1 x 10-2

Mortality

NOEC
LOEC

Dicentrarchus
labrax (Sea
Bass)

Mortality

(>50% died)

35 dph
~ 16 days

Decrease

40 days
58 days

1 x 10-1
40 days
200 days

1x 104
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Versonnen and
Janssen 2004
MacLatchy et
al. 2003
OrtizZarragoitia et
al. 2006
Nash et al.
2004
Andersen et al.
2004
Hill and Janz
2003
Blazquez et al.
1998

(Table 4 continued)
Organism
Response
Etheostoma
caeruleum
(Rainbow
Darter)
Etheostoma
caeruleum
(Rainbow
Darter)
Gambusia
affinis
(Western
Mosquitofish)

End
Point

Dose
(ppb)

Trend

1

Increase

Exposure
Time
6-21 days

Mortality

Mortality

Mortality

Reference
Elias et al.
2007

No
Effect

2 x 10-1

21 days

Elias et al.
2007

NOEL

1x 104

150 days

Angus et al.
2005

NOEL

1 x 10-4
μg/egg

1 day
Oryzias latipes
(Medaka)

Mortality
LOEL

Oryzias latipes
(Medaka)
Pimephales
promelas
(Fathead
Minnow)
Pimephales
promelas
(Fathead
Minnow)
Platichthys
flesus
(Starry,
European
Flounder)
Pomatoschistus
minutus
(Sand goby)

Mortality

5 x 10-4
μg/egg
1 x 10-4
–
1

Hano et al.
2005

Increase

85-110 days

Metcalfe et al.
2001

Mortality

5 x 10-2

Increase

0-13.3 days

Lange et al.
2003

Mortality

1 x 10-2

Decrease

21 days

Lange et al.
2003

Mortality

1 x 10-3
–
1 x10-2

Increase

21 days

Allen et al.
1999

Mortality

6 x 10-3

Increase

0 – 213.08 days

Robinson et al.
2003

There are a few documented cases in which populations did not decline. Danio rerio
(zebrafish) that were 20 days old post hatch exposed for 40 days evoked a slight decline in
mortality forming an NOEC of 3 x 10-2 ppb (Andersen et al. 2004). Tilapia aurea (tilapia)
yielded 94% survivorship forming a 40 day NOEL of 200000 ppb through dietary exposure
(Melard 1995). The following NOELS based on mortalities were recorded in Danio rerio
(zebrafish): a 33 day exposure to 1 x 10-1 ppb (Versonnen and Janssen 2004), and a 58 day
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exposure to 1 x 10-2 ppb (MacLatchy et al. 2003). Sexually immature Gambusia affinis (western
mosquitofish) fed EE2 through 150 days illustrated an NOEL of 1 x 104 ppb (Angus et al. 2005).
While an increase in fatality was observed in juvenile Etheostoma caeruleum (rainbow darter) in
1 ppb exposed for 6-21 days, exposure after 21 days in 2 x 10-1 ppb caused no effect on mortality
(Elias et al. 2007). Pimephales promelas (fathead minnow) displayed an increase in mortality on
days 0-13.3 in 5 x 10-2 ppb; however, a decrease in mortality was observed on day 21 in 1 x 10-2
ppb (Lange et al. 2003). An increase in survivorship was noted on days 26 and 30 yielding an
NOEC of 8 x 10-3 ppb Danio rerio (zebrafish) (Bogers et al. 2006).
Lethal Effects of Fluoxetine
Lethal concentrations (LC50s) were documented for different aquatic organisms (Table
5). A 24 hour LC50 was reported for Thamnocephalus platyurus (fairy shrimp) 8 x 102 ± 1 x
102 (Nalcz-Jawecki 2007). Juvenile Cyprinodon variegatus (sheepshead minnow) 43 – 63 days
old allocated were exposed to test concentrations 2 x 101 – 2 x 103.

Those organisms in the

highest concentration of 2 x 103 ppb sustained 47% mortality, causing the 96 hour LC50 to be
greater than 2 x 103 ppb (Henry et al. 2004). Oryzias latipes (Japanese medaka) larvae 6 x 103, 1
x 103, and 2 x 102 ppb at the respective pHs 7, 8, and 9 (Nakamura et al. 2008). The average 48
hour LC50s for Pimephales promelas (fathead minnow) were about 200 ppb for the R-fluoxetine,
S-fluoxetine, and the racemic-fluoxetine mixtures.
Table 5. Exposure times and concentrations of fluoxetine reported to provoke 50% lethality
(LC50s) in aquatic organisms.
Exposure time
Organism
Amount
Trend/Response
Reference
(ppb)
24 hours

Thamnocephalus platyurus
(Fairy Shrimp)

8 x 102

Lethality

Nalcz-Jawecki 2007

48 hours

Chironomus tentans
(Midge)

2 x 104

Mortality

Brooks et al. 2003b

48 hours

Hyalella azteca
(Scud)

> 4 x 104

Mortality

Brooks et al. 2003b
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(Table 5 continued)
Exposure time

Organism

Amount
(ppb)

Trend/Response

Reference

48 hours

Ceriodaphnia dubia
(Water Flea)

5 x 102

Increase in Mortality

Henry et al. 2004

48 hours

Ceriodaphnia dubia
(Water Flea)

2 x 102

Mortality

Brooks et al.2003b

Daphnia magna
(Water Flea)
Pimephales promelas
(Fathead Minnow)
Pimephales promelas
(Fathead Minnow)
Oryzias latipes
(Japanese Medaka)

8 x 102

Mortality

Brooks et al. 2003b

7 x 102

Mortality

Brooks et al. 2003b

~ 2 x 102

Mortality

Stanley et al. 2007

9 x 103

Mortality

Brooks et al. 2003b

Oncorhynchus mykiss
(Rainbow Trout)

2 x 103

Mortality

FDA-CDER 1996;
Eli Lilly and
Company 2005

Ceriodaphnia dubia
(Water Flea)
Daphnia magna
(Water Flea)
Cyprinodon variegatus
(Sheepshead Minnow)
Pimephales promelas
(Fathead Minnow)
Oryzias latipes
(Japanese Medaka)

3 x 102

Mortality

Brooks et al. 2003b

9 x 102

Mortality

Brooks et al. 2003b

> 2 x 103

Mortality (47%)

Winder et al. 2009

8 x 102

Mortality

Brooks et al. 2003b

2 x 103

Eli Lilly and
Company 2005

Oryzias latipes
(Japanese Medaka)

6 x 103
pH 7
1 x 103
pH 8
2 x 102
pH 9

Nakamura et al. 2008

48 hours
48 hours
48 hours
48 hours
48 hours
96 hours
96 hours
96 hours
96 hours
96 hours

96 hours

Fluoxetine enduced endpoints associated with mortality and/or survival (Table 6). The
24 hour LC50 of 600 ± 200 ppb for Spirostomum ambiguum (protozoan) was based on spherical
deformation and autolysis. The 24 hour EC50 of 400 ± 100 was based on different deformations
of morphological changes such as shortening, bending of the cell, etc (Nalcz-Jawecki 2007).
Juvenile Cyprinodon variegatus (sheepshead minnow) 43 – 63 days old allocated 2000 ppb
sustained 47% mortality, resulting in the 96 hour LC50 greater than2000 ppb, LOEC 2000 ppb,
and NOEC 1000 ppb. In concentrations 0, 50, 300, 500, 1000 ppb mortality remained greater
than or equal to 13% (Winder et al. 2009). Ceriodaphnia dubia (water flea) suffered 100%
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mortality in 2000 ppb after 7-8 days. Introduction to 90 ppb secured 0% mortality. The median
concentration of 400 ppb showed a decrease in survivorship (test concentration 20 – 3000 ppb)
(Henry et al. 2004).
Table 6. Exposure times and concentrations of fluoxetine reported to provoke the endpoints
associated with mortality or survivorship of aquatic organisms.
Organism
Response
Endpoint
Dose
Trend
Exposure Referenc
(ppb)
time
e
Spirostomum
ambiguum
(Protozoan)
Spirostomum
ambiguum
(Protozoan)

Deformation
and Autolysis

LC50

600

24 hours

Deformation

LC50

400

24 hours

Mortality

No effect

90

No effect

Mortality

2000

Decrease (100%)

Survivorship

400

Decrease

Ceriodaphnia
dubia
(Water Flea)

Cyprinodon
variegatus
(Sheepshead
Minnow)
Pimephales
promelas
(Fathead
Minnow)
Pimephales
promelas
(Fathead
Minnow)
Pimephales
promelas
(Fathead
Minnow)

NOEC

1000

LOEC

2000

NOEC

100

7-8 days
Henry et al.
2004

96 hours

Mortality

Survivorship
R-FLX

Survivorship
Rac-FLX

Survivorship
S-FLX

7 days
Decrease

LOEC

200

NOEC

100

7 days
Decrease

LOEC

200

NOEC

50

7 days
Decrease

LOEC

100

NalczJawecki
2007
NalczJawecki
2007

Winder et
al. 2009

Stanley et
al. 2007

Stanley et
al. 2007

Stanley et
al. 2007

Sublethal Effects
Biological diversity of pharmacodynamics, pharmacokinetics, and physiology may
produce unanticipated effects on organisms. Modification of the reproductive, immune, and
central nervous systems can alter hormones, development, and behavior that have not been
anticipated for non-target species (Fent et al. 2006).
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Ethinyl estradiol affects fecundity. Exposure to EE2 caused aquatic organisms to
experience changes in fecundity (Table 7). Danio rerio (zebrafish) frys 2 dph acquired had a
reduced mean egg production (Lin and Janz 2006). Adult Danio rerio (zebrafish) 223 dpf
showed a decrease in total number of eggs (Nash et al. 2004). Decreased egg production per
gram of females was observed in Tautogolabrus adspersus (cunner) (Gutjahr-Gobell et al. 2006).
The total number of eggs of Pimephales promelas (fathead minnow) adults decreased after EE2
exposure (Brian et al. 2007). An F1 generation study of Pimephales promelas (fathead minnow)
less than24 hpf embryos exposed for 301 dph showed a decrease number of eggs per female
breeding day (Lange et al. 2001).
The number of eggs per pair of Pimephales promelas (fathead minnow) 6-11 months old,
increased at 1 x 10-4 and 1 x 10-3 ppb; no eggs were produced in 1 x 10-1 ppb. Effects on
fertilization caused an NOEC and LOEC at 3 x 10-3 ppb and 8 x 10-4 ppb respectively. The
lowest concentration effecting progeny was 1 x 10-4 ppb (Pawlowski et al. 2004).
In one experiment, 15 dpf Danio rerio (zebrafish) larvae were exposed to 1 x 10-2 ppb
during different life stages. Based on fertilization success those exposed at 15 and 72 dpf were
not affected. The only significant time period was 43 dpf in which fertilization decreased;
additionally the mean number of eggs reported was significantly decreased. In another study, 15
dpf organisms were exposed for 28 days at different concentrations resulting in concentration
dependent reduction of fertilization success with an NOEL of 2 x 10-3 ppb and an LOEL of 3 x
10-3 ppb; the mean number of eggs per female per day was not significantly affected (Maack and
Segner 2004). Based on progeny counts of Nitocra spinipes (harpacticoid copepod), a decrease
in reproduction was observed (Breitholtz and Bengtsson 2001). An F1 generation study of
Cyprinodon variegates (sheepshead minnow) embryos showed a decrease in reproduction based
on progeny/ number of eggs per female reproductive day (Zillioux et al. 2001).
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Increase in eggs per spawning Pimephales promelas (fathead minnow) based on gamete
production in eggs (Brian et al. 2007). Adult Pimephales promelas (fathead minnow)
relinquished spawning completely after 28 days in less than1 x 10-2 ppb (Lange et al. 2001).
Decrease in reproduction frequency and fertility of Daphnia magna (water flea) neonates
exposed for 25 days (Goto and Hiromi 2003). Oryzias latipes (Japanese medaka) had a decrease
in fecundity, decreased number of spawning females, and decreased fertilization rate (Ma et al.
2005). Based on the average number of eggs per day per pair a decrease in
reproduction/fecundity of Oryzias latipes (Japanese medaka) was observed (Seki et al. 2002).
Reduction in the percent of Oryzias latipes (Japanese medaka) participating in copulatory
activity was reported (Balch et al. 2004). Oryzias latipes (Japanese medaka) embryos less than or
equal to 8 hpf showed increased germ cells counts; gamete production in gonads after injections
produced a 10 dph NOEC of 1 x 10-4 μg/egg and LOEC of 5 x 10-4 μg/egg (Hano et al. 2005). In
a generational effluent study of immature Pomatoschistus minutus (sand goby), 6 x 10-3 ppb
decreased the percentage of males nesting, percentage of pairs breeding, and overall number of
pairs (Robinson et al. 2003).
Table 7. Exposure times and concentrations of ethinyl estradiol reported to provoke the
endpoints associated with fecundity or reproduction of aquatic organisms.
Organism
Measured
End
Dose
Trend
Exposu Reference
Response
point
(ppb)
re time
Daphnia magna
(Water Flea)

Reproduction
Frequency

NOEC

5 x 102

Decrease

25 days

Nitocra spinipes
(Harpacticoid
Copepod)

Reproduction/
Progeny counts

NOEC

5 x 101

Decrease

15-18
days

NOEC
Cyprinodon
variegates
(Sheepshead Minnow)

Reproduction/
Progeny counts

2 x 10

-2

LOEC

9 x 10-2
–
1

MATC

6 x 10-2
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Decrease in
eggs per
female
F1 generation
study

73 days

Goto and
Hiromi 2003
Breitholtz
and
Bengtsson
2001

Zillioux et al.
2001

(Table 7 continued)
Organism
(Danio rerio
(Zebrafish)

Measured
Response

End
point

Dose
(ppb)

Fertilization
Success

No
effect

1 x 10-2

Trend

Exposu
re time

Reference

15 dpf

Maack and
Segner 2004

72 dpf
Decrease

Danio rerio
(Zebrafish)

Fertilization
Success

Danio rerio
(Zebrafish)

Gamete
Production

Danio rerio
(Zebrafish)

Gamete
Production

Oryzias latipes
(Medaka)

Fecundity

NOEL

2 x 10-3

LOEL

3 x 10-3

LOEL

1 x 10-3

NOEL

5 x 10-3

LOEL

5 x 10-2

NOEC

3 x 10-1

LOEC

5 x 10-1

*Mean number
of eggs per
female per day
not significant
Decrease in
mean egg
production
Decrease in
total number
of eggs
Decrease
based on
average
number of
eggs per day
per pair

28 days
Maack and
Segner 2004

58 days
10 days

Lin and Janz
2006
Nash et al.
2004

0-21
days

Seki et al.
2002

28 days

Ma et al.
2005

Decreased

Oryzias latipes
(Medaka)

Oryzias latipes
(Medaka)

Fecundity

Gamete
Production

LOEL

NOEC

1 x 10-1

1 x 10-4
μg/egg

NOEL

5 x 10
μg/egg
2 x 10-3

LOEL

1 x 10-2

Gamete
Production

NOEC

1 x 10-3
–
2 x 10-3

Pimephales promelas
(Fathead Minnow)

Gamete
Production

NOEC

5 x 10-4

Pimephales promelas
(Fathead Minnow)

Number
Spawning

NOEL

6 x 10-4
and
2 x 10-3

Mounting/
Copulation/
Intercourse

Pimephales promelas
(Fathead Minnow)

*Decreased
fertilization
rate
Increase in
germ cells
counts

10 dph

-4

LOEC
Oryzias latipes
(Medaka)

*Decreased
number of
spawning
females
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Decrease
Decrease in
total number
of eggs
Increase in
eggs per
spawning

Hano et al.
2005

121.76 –
182.64
days

Balch et al.
2004

21 days

Brian et al.
2007

21 days

Brian et al.
2007

21 day

Brian et al.
2007

(Table 7 continued)
Organism

Measured
Response
Fertilization

Pimephales promelas
(Fathead Minnow)

Pimephales promelas
(Fathead Minnow)
Pimephales promelas
(Fathead Minnow)

Number of eggs
per pair
No eggs produced
Progeny
Spawning
Progeny
(number of eggs
per female
breeding day)

End
point

Dose
(ppb)

NOEC

3 x 10-3

LOEC

LOEC

8 x 10-4
1 x 10-4
1
x 10-3
1 x 10-1
1 x 10-4

NOEC

< 1 x 10-2

NOEC

≥ 8 x 10-4

LOEC

> 8 x 10-4

% Males nesting
Pomatoschistus
minutus (Sand goby)

Trend

% Pairs breeding

21 days

Dreissena
polymorpha
(Zebra Mussels)
Males

Spawning

Dreissena
polymorpha
(Zebra Mussels)
Females

Spawning

Pawlowski et
al. 2004

Increase

Total Lack of
spawning
Decrease

28 days

Lange et al.
2001

301 dph
Lange et al.
2001

6 x 10

-3

Decrease

generational
effluent
study

Robinson et
al. 2003

Decrease
Decrease per
gram female

Egg Production

Reference

Decrease

Overall number
of pairs

Tautogolabrus
adspersus (Cunner)

Exposu
re time

NOEL

5 x 102

LOEL

3 x 103
5 x 10-7
–
5 x10-4
M of
FLX
5 x 10-6
and 10 -5
M of
FLX

LOEC
200 E-5
P

Dreissena
polymorpha
(Zebra Mussels)
Males

Sperm Motlility

5 x 10-3 –
5 x 10-5
M of
FLX

Dreissena
polymorpha
(Zebra Mussels)
Males

Growth and
Development

1 x 10-3
M of
FLX

*Additionally observed trends
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*Increase of
egg viability at
0.05 mg/kg

spawned
within
the first hour

14 days

GutjahrGobell et al.
2006

Fong 1998

Fong 1998
not motile
*But, sperm
recovered
motility
when placed in
fresh lake
water

Fong 1998

looked
unhealthy

Fong 1998

Fluoxetine affects fecundity. Exposure to FLX caused changes in the fecundity of
aquatic organisms (Table 8). Reproduction effects modulated by serotonin vary between
different phyla (Fent et al. 2006). In vivo exposure of 0.5 mg/mL of FLX for 1 hour induced
egg laying in Caenorhabditis elegans (nematoda roundworm) (Dempsey et al. 2005).
Chironomus tentans (diptera: chironomidae) egg clutches exposed to 6 ppb of Fluoxetine
contained significantly more eggs (515 ± 194) than the control (316 ± 214) (Williams and
Herrup 1988). Ceriodaphnia dubia (water flea) exposed for 7 days had LOEC 400 and NOEC 90
ppb for both the reduction in number of broods produced and the reduction of neonates (Henry et
al. 2004). A similar NOEC of 60 ppb based on reduced number of neonates in was observed by
Brooks et al. (2003).
Fluoxetine administered at 1 ppb amplified 5-HT and induced stimulation of parturition
of Sphaerium straitium (fingernail clam) (Fong et al. 1998). Procambarus clarkii (red swamp
crayfish) injected with 15 μg/g body weight fluoxetine in vivo at 1, 5, 10, and 15 days, increased
ovarian index and oocyte size, and amplified 5-HT-induced effects (Kulkarni et al. 1992).
Serotonin promotes oocyte maturation in Oryzias latipes (Japanese medaka) (Iwamatsu et
al. 1993) and in some bivalves and crustaceans as well as induced spawning (Fong 2001) at 50
nM in males and 5 µM in female Dresissena polymorpha (Zebra mussel) (Fong 1998) and at 1
ppb in vivo for Macoma balthica (Baltic clam) and created an extension of spawning season
(Honkoop et al. 1999).
Chironomus riparius (midge) showed no effect in reproduction measured concentrations
up to 60 ppb (Péry et al. 2008). Oryzias latipes (Japanese medaka) exposed for 4 weeks to
fluoxetine at concentrations of 100–5000 ppb, had no effect on vitellogenin plasma content,
plasma steroids, fecundity, egg fertilization or hatching rate (Foran et al. 2004). This indicates
that FLX concentrations up to 5 ppb do not impair reproduction in this fish. A significant
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decrease of reproduction was observed in Potamopyrgus antipodarum (snail) at 10 ppb with a
reproduction success LOEC of 5 x 10-2 ppb (Péry et al. 2008). Fecundity of Ceriodaphnia dubia
(water flea) was decreased by fluoxetine treatments of 200 ppb (Brooks et al. 2003 a; b).
However, C. dubia fecundity was significantly increased after 7 day exposure of 60 ppb
fluoxetine (Brooks et al. 2003b) producing an NOEC of 60 ppb and an LOEC of 100 ppb
(Brooks et al. 2003). Doses of FLX (1400, 2800, 5600, 11200, 22400 ppb) appeared to stimulate
reproduction in Hyalella azteca (scud) (Brooks et al. 2003 a, b). It is assumed that enhanced
fecundity may be brought about by increased serotonin levels (Brooks et al. 2003b). Studies
indentified that minimal quantities may trigger advanced fecundity; however, increased egg and
neonate production is often associated with reduced egg and neonate body size (Bodar et al.
1988; Ebert 1993).
Table 8. Exposure times and concentrations of fluoxetine reported to provoke the endpoints
associated with fecundity or reproduction of aquatic organisms.
Organism
Measured
End
Dose
Trend
Exposu Reference
Response
point
(ppb)
re time
Caenorhabdtis
elegans
(Nematoda
Roundworm)
Chironomus
tentans
(Diptera:
Chironomidae)

Egg laying

Egg clutches

0.5 mg/mL
of FLX

Induce

6 of FLX

Significantly
more eggs than
the control

1 hour

Dempsey et
al. 2005
Williams
and Herrup
1988

Decrease

Ceriodaphnia dubia
(Water Flea)

Progeny counts/
Number

NOEC

9 x 10

1

*Reduced
number of
neonates

7 days

Henry et al.
2004

*Reduced
number of
broods
Ceriodaphnia dubia
(Water Flea)
Ceriodaphnia dubia
(Water Flea)

Number of
neonates
Fecundity

LOEC

4 x 102

NOEC

6 x 101

Decrease

2 x 102

Decrease
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Brooks et al.
2003
Brooks et al.
2003 a; b

(Table 8 continued)
Organism

Measured
Response

Ceriodaphnia dubia
(Water Flea)

Fecundity

Chironomus riparius
(Midge)

Reproduction

End
point

Dose
(ppb)

Trend

NOEC

6 x 101

Increase

LOEC

1 x 10

2

No
effect

6 x 101

Exposu
re time
7 days

Reference
Brooks et al.
2003 a; b
Péry et al.
2008

1 x 103
3 x 103
Hyalella azteca
(Scud)

6 x 103

Reproduction

Brooks et al.
2003 a,b

Stimulates

1 x 104
2 x 104
50 Nm male

Dresissena
polymorpha
(Zebra Mussel)

Spawning

Macoma balthica
(Baltic Clam)
Potamopyrgus
antipodarum
(Snail)
Potamopyrgus
antipodarum
(Snail)

Induced
Spawning

5 µM in
female

*Promotes
oocyte
maturation
Induced

Spawning

1

*Extension of
spawning
season

Reproduction

1 x 10-1

Decrease

Reproduction
Success

LOEC

Fong 1998

Honkoop et
al. 1999

Péry et al.
2008
Péry et al.
2008

5 x 10-1
Increase

Procambarus clarkia
(Red Swamp
Crayfish)

Ovarian index
and oocyte size

15 μg/g
body weight

Sphaerium straitium
(Fingernail Clam)

Parturition

1

Oryzias latipes
(Japanese Medaka)

Oryzias latipes
(Japanese Medaka)

Oocyte
maturation
Vitellogenin
plasma content
Plasma steroids
Fecundity
Egg fertilization
Hatching rate

*Amplified 5HT-induced
effects
Induced

1, 5, 10,
and 15
days,

Fong et al.
1998

*Amplified 5HT

Iwamatsu et
al. 1993

Serotonin

No
effect

1 x 102
–
5 x 102

*Additionally observed trends
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Kulkarni et
al. 1992

4
Weeks

Foran et al.
2004

Ethinyl estradiol affects growth and development. Aquatic organisms exposed to EE2
exibited changes in normal growth and development (Table 9). The following organisms
showed a decrease in whole body growth based on length, and weight: Oryzias latipes (medaka)
(5 μg/organism) (Papoulias et al. 2001), Pomatoschistus minutus (sand goby) (6 x 10-3 ppb)
(Robinson et al. 2003), and Danio rerio (zebrafish) (58 day LOEC 1 x 10-2 ppb) (Lin and Janz
2006).
A decrease in length in Danio rerio (zebrafish) (Andersen et al. 2004) and in
Dicentrarchus labrax (sea bass) (Blazquez et al. 1998).
Increased length was recorded in Acartia tonsa (calanoid copepod) (Andersen et al.
2004), Oncorhynchus tshawytscha (chinook salmon) (Piferrer and Donaldson 1992), and in
Salvelinus namycush (lake trout) (Werner et al. 2003).
Decrease in weight in Anguilla Anguilla (common eel) (Versonnen et al 2004) and in
Carassius auratus (goldfish) (Martyniuk et al. 2006). Bogers et al. (2006) observed an increase
in whole body weight in Danio rerio (zebrafish).
A decrease in length and weight was observed in fathead minnows exposed for 37 days.
Additional exposure produced effects on length. Those exposed until 301 days post hatch
showed no effect on length (Lange et al. 2001).
Danio rerio (zebrafish) were reported to have a decrease in weight but an increase in
length (Lin and Janz 2006). Decrease in progeny developmental stage in Danio rerio (zebrafish)
based on swim-up breeding trial begun 240 days post hatch after 6 months recovery with no
exposure, a decrease in stage development of the progeny (offspring) was found (Lin and Janz
2006).
Acartia tonsa (calanoid copepod) exposed for 5 days showed a decrease in larval
development (Andersen et al. 2001). Hyalella azteca (scud) exposed to 10 ppb exhibited a
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decrease in sexual development of Gnathopod (modified jaw) but showed an increase in length
of antenna (Vandenbergh et al. 2001). Oncorhynchus mykiss (rainbow trout) (Verslycke et al.
2002) and Acipenser flvescens (lake sturgeon) showed an increase in the weight of the gonad in
relationship to body. Also observed was an increase in liver weight in relationship to body in
Acipenser flvescens (lake sturgeon) (Palace et al. 2001), Oncorhynchus mykiss (rainbow trout)
(Verslycke et al. 2002), and Ictalurus punctuates (channel catfish) (Nimrod and Benson 1996).
Table 9. Exposure times and concentrations of ethinyl estradiol reported to provoke the
endpoints associated with growth and development of aquatic organisms.
Organism
Measured
Exposure
End
Dose Trend
Reference
Response
time
point
(ppb)
Acartia tonsa
(Calanoid Copepod)

Larval
Development

Acartia tonsa
(Calanoid Copepod)

Larval
Development

5 days

Acartia tonsa
(Calanoid Copepod)

Length

18 days

Hyalella azteca
(Scud)

Sexual
Development
of Gnathopod
(modified jaw)

28 days

Length of Antenna

28 day

Weight
Weight

Hyalella azteca
(Scud)
Anguilla Anguilla
(Common Eel)
Anguilla Anguilla
(Common Eel)

5 days

EC50

4 x 101
–2x
102
3 x 10-

Decrease

Anderson et al.
2001

2

Increase

Anderson et al.
2004

1 x 101

Decrease

Vandenbergh et
al. 2003

NOEC

1 x 101

Increase

9 day

NOEL

1 x 101

Decrease

15 day

NOEL

1 nM

Decrease

NOEC

6 x 10
Acipenser flvescens
(Lake Sturgeon)

Acipenser flvescens
(Lake Sturgeon)

Anderson et al.
2001

9 x 101

Vandenbergh et
al. 2003
Versonnen et al.
2004
Versonnen et al.
2004

-

2

Weight of Gonads

25 days

–
1
1 x 10-

Increase

Palace et al. 2001

Increase

Palace et al. 2001

Decrease

Martyniuk et al.
2006

Decrease

Lin and Janz
2006

Decrease

Andersen et al.
2004

2

Weight of Liver

25 days

–
6 x 102

Carassius auratus
(Goldfish)

Weight

15 days

NOEL

Danio rerio
(Zebrafish)

Length
and
Weight

58 days

LOEC

Danio rerio
(Zebrafish)

Weight

NOEC
40 days

Length

LOEC
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1 nM
1 x 102

3 x 102

3 x 102

Decrease

(Table 9 continued)
Organism
Measured
Response
Danio rerio
(Zebrafish)
Danio rerio
(Zebrafish)
Danio rerio
(Zebrafish)
Dicentrarchus
labrax
(Sea Bass)
Ictalurus
punctuates
(Channel
Catfish)
Oncorhynchus
mykiss
(Rainbow Trout)
Oncorhynchus
mykiss
(Rainbow Trout)
Oncorhynchus
tshawytscha
(Chinook
Salmon)
Oryzias latipes
(Medaka)
Pimephales
promelas
(Fathead
Minnow)
Pimephales
promelas
(Fathead
Minnow)
Pimephales
promelas
(Fathead
Minnow)
Pomatoschistus
minutus
(Sand Goby)
Salvelinus
namycush
(Lake Trout)

Weight
Length
Weight
Developmental stage
of Progeny
Length

Weight of Liver

Exposure
time

Dose
(ppb)

Trend

Referenc
e

1 x 10-3
–
8 x 10-3

Increase

Bogers et
al. 2006

NOEC

1 x 10-2

Increase

Lin and
Janz 2006

NOEC

1 x 10-2

Decrease

58 days

LOEC

1 x 10

-2

Decrease

Hill and
Janz 2003

200 days

LOEC

1x 104

Decrease

Blazquez
et al. 1998

Increase

Nimrod
and
Benson
1996

Increase

Verslycke
et al. 2002

Increase

Verslycke
et al. 2002

30 days

58 days

7 days

Weight of Gonads

7 days

Weight of Liver

7 days

Length

184 days
post hatch

Length and Weight

105 days

Length and Weight

End
point

7 x 10

2

1x 103
–
5x 103
1x 104
and
3 x 104
NOEC

4 x 10

2

Increase

5 μg/
organism

Decrease

1 x 10-2

Decrease

37 days

Piferrer
and
Donaldson
1992
Papoulias
et al. 2001
Lange et
al. 2001

1

Length

Length

Length and Weight

Length

56 days post
hatch
301 days
post hatch

LOEC

3 x 10-3

Decrease

Lange et
al. 2001

NOEC
and
LOEC

> 8 x 10-4

Decrease

Lange et
al. 2001

6 x 10-3

Decrease

Robinson
et al 2003

NOEC

4 x 103

Increase

LOEC

2 x 10-2
–
4

0-213.08
days

21 days
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Werner et
al. 2003

Fluoxetine affects growth and development. Aquatic organisms exposed to FLX
exhibited changes in normal growth and development (Table 10). Chironomus riparius did not
exhibit any significant effects on growth for concentrations up to 6000 ppb in the sediment
(Nentwig 2006). The median effective concentration (MICs), the lowest concentration of an
antimicrobial that will inhibit the visible growth of a microorganism after overnight incubation,
were established for the following: S. capricornutum (green algae), Chaetomium globosum
(fungus), Aspergillus flavus (mold), Pseudomonas acidovorans (soil bacteria), Azotobacter
chroococcum (N-fixing bacteria), and Nostoc sp. (blue-green algae) (Eli Lilly and Company
2005). The growth of Hyalella azteca (Scud) produced an NOEC of 30 ppb and an LOEC of 100
ppb (Péry et al. 2008). Brooks et al. (2003) found an LOEC of 6000 ppb.
Although F1 generation Daphnia magna (water flea) showed much more pronounced
effects in the sense that they were longer length, they still had the same NOEC and LOEC as the
F0 generation. A slight decrease in length was observed at 3 ppb. At this concentration the
organisms’ length was between that of the NOEC and LOEC; however, this concentration was
not significant because the length of the organisms in the NOEC (10 ppb) was close to those in
the control (Péry et al. 2008).
Based on growth, Chironomus tentans (midge) had an LOEC of 1000 ppb (Brooks et al.
2003). Pimephales promelas (fathead minnow) exposed to FLX exhibited decreased growth and
feeding rates (Stanley et al. 2007).
Female Gambusia affinis (western mosquitofish) were significantly longer and larger
(wet weight) than males at the end on the 91 day exposure period. The number of females
remained 49 – 54% in each treatment and the control. Few fish had enlogated anal fins;
however, neither control nor exposed fish developed a mature gonopodium with completely
formed hooks. Sexual maturity was delayed in female and males from the juvenile stage (59
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days) to the adult stage (159 days) as indicated by the development of a black spot (female) and
elongated anal fin (males). In this experiment the number of females in control and all
treatments was 54 -57%. At 70 ppb, the number of organisms developing a black spot on the
posterior portion of the abdomen was significantly lower as well as the number growing an
elongated anal fin (Henry and Black 2008).
Table 10. Exposure times and concentrations of fluoxetine reported to provoke the endpoints
associated with growth and development of aquatic organisms.
Organism
Measured End point
Dose
Trend
Exposure
Reference
Response
(ppb)
time
Aspergillus flavus
(Mold)
Azotobacter
chroococcum
(N-fixing Bacteria)
Chaetomium
globosum
(Fungus)
Pseudomonas
acidovorans
(Soil Bacteria)
Nostoc sp.
(Blue-Green
Algae)
S. capricornutum
(Green Algae)
Chironomus
riparius
Chironomus
tentans (Midge)

Hyalella azteca
(Scud)

Growth
Rate

MIC

6 x 104

Growth
Rate

MIC

6 x 104

Growth
Rate

MIC

6 x 104

Growth
Rate

MIC

1 x 106

Growth
Rate

MIC

3 x 105

Growth
Rate

MIC

3 x 101

Growth

No effect

6 x 103

Growth

LOEC

1 x 103

NOEC

3 x 101

LOEC

1 x 102

LOEC

6 x 103

NOEC

1 x 101

LOEC

3 x 101

Growth

Daphnia magna
(Water Flea)
(F0 and F1
generation)

Length

Gambusia affinis
(Western
Mosquitofish)

Growth,
length and
wet weight

5 x 10-2
5 x 10-1
5
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Eli Lilly and
Company
2005
Eli Lilly and
Company
2005
Eli Lilly and
Company
2005
Eli Lilly and
Company
2005
Eli Lilly and
Company
2005
Eli Lilly and
Company
2005
Nentwig
2006
Brooks et al.
2003
Péry et al.
2008
Brooks et al.
2003
F1 generation
longer length

21 days

Females
significantly
longer and
larger

91 days

Péry et al.
2008

Henry and
Black 2008

(Table 10 continued)
Measured
Organism
Response

Gambusia affinis
(Western
Mosquitofish)

Black spot
on the
posterior
portion of
the
abdomen
(females)
Number
growing an
elongated
anal fin
(males)

Pimephales
promelas
(Fathead Minnow)

Growth
R-FLX

Pimephales
promelas
(Fathead Minnow)

Growth
Rac-FLX

Pimephales
promelas
(Fathead Minnow)

Growth
S-FLX

Pimephales
promelas
(Fathead Minnow)

End point

Dose
(ppb)

Trend

Exposure
time

Reference

Decrease
70

100 days
Henry and
Black 2008
Decrease

70
No
response

0, 7, 70

NOEC

1 x 102

LOEC

2 x 10

2

NOEC

1 x 101

LOEC

5 x 101

NOEC

1 x 101

LOEC

5 x 101

Feeding
Rates
R-FLX

NOEC

1 x 102

LOEC

2 x 102

Pimephales
promelas
(Fathead Minnow)

Feeding
Rates RacFLX

NOEC

5 x 101

LOEC

1 x 102

Pimephales
promelas
(Fathead Minnow)

Feeding
Rates
S-Flx

NOEC

1 x 101

LOEC

1

5 x 10

49-59 days

Not different
from control

73-100 days

No effect

7 days

Stanley et al.
2007

Decrease

7 days

Stanley et al.
2007

Decrease

7 days

Stanley et al.
2007

Decrease

7 days

Stanley et al.
2007

Decrease

7 days

Stanley et al.
2007

Decrease

7 days

Stanley et al.
2007

Impacts on Nontarget Organisms
The U.S. Geological Survey has established a baseline for pharmaceuticals and personal
care products as ―emerging pollutants‖ in the United States (Kolpin et al. 2002). The baseline
states that these contaminants have to potential to affect the health and welfare of aquatic
ecosystems and humans (Khetan et. al 2007). Pharmaceuticals with modes of action depending
upon signal transduction, cell division, and key metabolizing enzymes can be hazardous to
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nontarget organisms that possess these necessary human features to carry out the drugs function
(Nelson et al. 1996). If nontarget organisms lack the necessary attributes for the specified mode
of action, disparate modes of action will transpire resulting in unanticipated effects (Fent et al.
2006).
Biochemical reactions that have been identified in humans may not justify irregularities
observed in animals. Because of the limitations in understanding biochemical signaling
pathways, drugs also act by other routes and on nontargeted tissues and organisms. Even if the
pharmaceutical were capable of reacting with a single type of receptor, the tissue distribution of
the receptor may not be fully understood. With this in mind, potential actions and biochemical
effects on nontarget aquatic ecosystems are not entirely realized or identified (Daughton and
Ternes 1999). Although these chemicals are present in extremely low concentrations, this does
not belittle their potential to cause harm to the environment. Pharmaceuticals are designed to
produce a response at low levels (Halford 2008). Minute amounts of chemicals, typically
considered safe because they occur at trace amounts, can elicit unanticipated effects on
ecosystems as evident by xenobiotics such as DDT and PCBs which have hormone mimicking
effects on the reproductive systems of organisms at nanograms/L (Colbum and Clement 1992).
Ethinyl Estradiol Performance in Animals
The binding affinity for the estrogen receptor in fish is correlated with the relative
potency of the sex steroid (Papoulias et al. 1999). Research led by John Sumpter, an
ecotoxicolgist at England’s Brunel University, linked the presence of the synthetic birth control
compound 17α-ethinylestradiol to the feminizing phenomenon (Desbrow et al. 1998). In the
1990s reports from the United Kingdom and the United States fish living downstream from
wastewater treatment plants exhibited several reproductive abnormalities including but not
limited to changes in the levels of sex steroids, hermaphroditism, and increased levels of
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vitellogenin (the female egg yolk precursor) in male fish (Beven et al. 1996; Folmer et al. 1996;
Harries et al. 1996; Purdom et al. 1994; and Jobbing et al. 1998). These abnormalities are
deemed feminization because fish that are genetically male exhibit female sex characteristics
(Papoulias et al. 1999).
Pimephales promelas (fathead minnow) embryos 48-60 hours post fertilization exposed
106 – 150 days post hatch developed secondary sex characteristics (Parrott and Blunt 2005).
After injections of EE2 in Oryzias latipes (medaka) embryos less than or equal to 8 hpf exposed
for 100 dph began to exhibit abnormal morphology of the gonads after injection. The XY males
displayed phenotypic female characteristics; ovaries actively produced maturing oocytes in the
postvitellogenic phase and papillary processes on the anal fin were void (Hano et al 2005).
Precocious sexual development of genital papillae was observed in juvenile Etheostoma
caeruleum (rainbow darter) 120 days post hatch and progressively increasing. Also reported
with the same endpoints was an increase in imposex/intersex conditions (Elias et al. 2007).
Mature Oryzias latipes (medaka) about 6 months post hatch manifested an increase in
morphology of intersex gonads based on testis-ova (Seki et al. 2002). Dicentrarchus labrax (sea
bass) exposed to 10000 ppb through diet displayed smaller size gonads than control and
instances of intersex and sterile gonads (Blazquez et al. 1998). Margariscus margarita (pearl
dace) had a reduction of the developmental stage of ovaries with reduction of vitellogenic
oocytes (Palace et al. 2006).
Lai et al. (2002) found that 6 x 10-3 ppb of EE2 produced 100% female Danio rerio.
Tilapia aurea (tilapia) fed 50,000 ppb EE2 for 19 days yielded 100% sex reversal (Nakamura
and Takahashi 1973; Papoulias et al. 1999). The estimated dosage to produce 50% XY female
Oryzias latipes (medaka) is 2000 ppb EE2, 6000 ppb estradiol (E2), and 20000 mg/g estrone
(Yamamoto 1975) in (Papoulias et al. 1999). Primary germ cell number and gonad size of
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medaka signify that sex reversal has occurred by about 6 days post hatch (Papoulias et al. 1999).
Sex reversal demonstrates the plasticity and vulnerability of gonads (Papoulias et al. 1999).
A decrease in the morphology of testes was observed in Oncorhynchus mykiss (rainbow
trout) after 62 days (Schultz et al. 2003). Testes size diminished in relationship to the body of
Oncorhynchus mykiss (rainbow trout) (Jobling et al. 1996) and in Danio rerio (zebrafish) greater
than240 days post hatch (Lin and Janz 2006).
Decrease in renal somatic index, GSI (gonadosomatic indices: gonad weight/body weight
x 100), and HSI (Hepatomsomatic indices liver weight) were indicated in sexually mature
Gobiocypris rarus (Chinese rare minnow) 7 months old. Males were generally more sensitive
than females (Zha et al. 2007).
Fewer motile sperm in adult Danio rerio (zebrafish) after 21 days (Santos et al. 2007)
with an NOEL based on sperm motility of 5 x10-4 and an LOEL of 5 x10-3. A decreased sperm
count was observed giving an LOEL of 2 ppb in juvenile Poecilia reticulate (guppy) less than or
equal to 7 days old; however, a significant increase of the sperm count was observed at 1 x 10-2
ppb (Nielsen and Baatrup 2006). A reduction in number of normal development of tubercles
(which are features of males) after 21 days in mature Pimephales promelas (fathead minnow) 611 months old instituted an NOEC of 1 x 10-4 ppb and an LOEC of 7 x 10-4 ppb (Pawlowski et
al. 2004). Tubercles of adult male Pimephales promelas (fathead minnow) developed
abnormally after exposure to EE2 for 21 days. A decrease in the number of normal developed
tubercles occurred at 5 x 10-4 ppb and 1 x 10-3 – 2 x 10-3 ppb. The lesser concentrations caused a
higher instance of prominent tubercles. The higher concentrations caused a decrease in the
normal shape/prominence of tubercles. Decrease in normal shape/promincence of tubercles
NOEC 5 x 10-4 ppb; increase in normal shape/prominence of tubercles/size NOEL 5 x 10-4 ppb
(Brian et al. 2007). An NOEL based on the sexual development of the mean number of tubercles
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in Pimephales promelas (fathead minnow) adults (Bogers et al. 2007). These studies reaffirm
what Kidd et al. (2007) conveyed; even at low concentrations, if estrogen is present at a
measurable concentration feminization has the potential to occur.
Table 11. Exposure times and concentrations of ethinyl estradiol reported to provoke the
endpoints associated with abnormalities of aquatic organisms.
Organism
Measured
End
Dose
Trend
Exposure
Reference
Response
point
(ppb)
time
Danio rerio
(Zebrafish)
Danio rerio
(Zebrafish)
Danio rerio
(Zebrafish)

Sex Reversal

6 x 10-3

100% females

Testes Size

1 x 10-2

Decrease

>240 dph

5 x 10-4
5 x 10-3

Decrease

21 days

1 x 104

Decrease;
sterile gonads

200 days

NOEC

2 x 10-2

No Effect

LOEC

2

Increase

Sperm motility

NOEL
LOEL

Lai et al. 2002
Lin and Janz
2006
Santos et al.
2007

Dicentrarchus
labrax (Sea
Bass)
Etheostoma
caeruleum
(Rainbow
darter)
Gobiocypris
rarus (Chinese
Rare Minnow)
Margariscus
margarita
(Pearl dace)
Oncorhynchus
mykiss
(Rainbow
Trout)

Size of Kidney

LOEC

1 x 10-3

Decrease

28 days

Zha et al. 2007

Developmental Stage
of Ovaries

LOEL

5 x 10-3

Decrease

882.76 days

Palace et al.
2006

2 x 10-3

Decrease

21 days

Jobling et al.
1996

Oryzias latipes
(Medaka)

Abnormal
Morphology of
Gonads

Oncorhynchus
mykiss
(Rainbow trout)

Morphology of
Testes

Oryzias latipes
(Medaka)

Morphology of
Intersex
Gonads

Oryzias latipes
(Medaka)

Gonad Size
Sexual
Development
of Genital
Papillae

21 days
Elias et al. 2007

Weight of
Testes

Sex Reversal –
estimated dose
to produce
50% XY
females

Blazquez et al.
1998

NOEC
LOEC

1 x 10-4
μg/egg
5x 10-4
μg/egg

LOEC

1

NOEC

3 x 10-2

LOEC

6 x 10

-2

EE2

2 x 103

Estradiol
(E2)

6 x 103

Estrone

20,000
mg/g

50

100 dph

Decrease

62 day

Increase

21 days

Hano et al.
2005
Schultz et al.
2003
Seki et al. 2002

Yamamoto
1975 in
Papoulias et al.
1999

(Table 11 continued)
Organism
Measured
Response
Oryzias latipes
(Medaka)
Pimephales
promelas
(Fathead
Minnow)
Pimephales
promelas
(Fathead
Minnow)

Pimephales
promelas
(Fathead
Minnow)

Pimephales
promelas
(Fathead
Minnow)
Poecilia
reticulate
(Guppy)

Tilapia aurea
(Tilapia)

Sex Reversal –
primary germ
cell number
and gonad size
Development
of Secondary
Sex
Characteristics
Sexual
Development
—number of
normal
developed
tubercles
Number of
normal
developed
tubercles
Normal
shape/promine
nce of
tubercles
Normal
shape/promine
nce of
tubercles/size
Sexual
Development
– Mean
number of
tubercles

End
point

Dose
(ppb)

Trend

NOEC

1 x 10-4

NOEL

5 x 10-2

NOEC

5 x 10-4
and
1 x 10-3 – 2
x 10-3

LOEC

7 x 10-4

NOEC

1 x 10-3
–
2 x 10-3

Decrease

NOEC

5 x 10-4

Decrease

NOEL

5 x 10-3

Increase

NOEL

3 x 10-4

LOEL

1 x 10-3

LOEL

2

Exposure
time

Reference

6 days post
hatch

Papoulias et al.
1999

106 – 150 dph

Sperm count
1 x 10

Sex reversal

Decrease

21 days

Parrott and
Blunt 2005

Pawlowski et
al. 2004

21 days

Brian et al.
2007

28 days
Bogers et al.
2007
Decrease

108 days

Significant
Increase

-2

100% sex
reversal

5 x 104

19 days

Nielsen and
Baatrup 2006
Nakamura and
Takahashi
1973;
Papoulias et al.
1999

Fluoxetine Performance in Animals
It is plausible to assume that SSRIs could produce similar pharmacological responses in
fish as those seen in humans and other mammals (Kreke and Dietrich 2008). However, due to
interactions with other neurotransmitters and hormones along with the complexity of the
serotonergic system, ―the downstream effects of SSRI action on known pharmacological target
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molecules in fish may differ considerably‖ (Kreke and Dietrich 2008). Selective Serotonin
Reuptake Inhibitors may produce effects in fish not seen in humans due to phylogenic
differences in transduction pathways (i.e. those not present or differently regulated) (Kreke and
Dietrich 2008). A broad range of effects and the ability for bodily chemicals to neutralize and
return to normal after increases of serotonin suggests that a traditional dose-response relationship
may not be expected with chronic exposure (Brooks et al. 2003a).
Fluoxetine may adversely influence the function of the nervous system and associated
hormonal systems of organisms possessing serotonin. In addition to operating as a
neurotransmitter, serotonin functions as a hormone directly impacts the immune system, alters
appetite, modulates sexual function, and influences the establishment of social hierarchies
through disruption in sexual behavior and aggressive interactions (Barton et al. 2002; Fent et al.
2006).
The pineal hormone melatonin is a derivative of serotonin and is thought to modulate
aggressive behavior and may be an explanation for submissive behavior of organisms exposed to
SSRIs (Lee et al. 2004). A study on Oncorhynchus mykiss (rainbow trout) using melatonin,
tryptophan, and the SSRI citalopram, concluded that it is the 5-HT that is the antiaggressive
agent in fish. The melatonin group had no significant effect while the other two group decreased
aggression and lowered plasma controls (Metcalfe et al. 2001). Derivatives of serotonin can
affect sensory perception (i.e. visual perception) thus disrupting the circandian system which
regulates organisms’ measurement and interpretation of day duration. Animals that rely on
photoperiodic signals can be affected by this. Slight changes in extracellular 5-HT may alter
behavior output by modulating other signaling cascades and could result in abnormities in
circadian rhythmic activities including but not limited to sleep, feeding patterns, hunting,
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reproductive behavior, core body temperature, brain wave activity, cell regeneration, and
hormone production (Kreke and Dietrich 2008).
After four week exposure levels of 100 and 500 ppb FLX, female circulating steroid
concentrations (E2) increased significantly in Japanese medaka (Weston et al. 2003). The
modified circulating steroids confirms unpredicted responses including but not limited to sexual
dimorphisms in P450 activity and potential sexual dimorphisms in serotonin systems
(Hernandez-Rauda et al. 1999). In some bivalves and crustaceans induced spawning (Fong
2001). The induction of mussel spawning points to interference in serotonergic action. In
invertebrates, serotonin may stimulate ecdysteroids, ectysone and juvenile hormone, responsible
for controlling oogensis and vitellogensis (Nation, 2002). Serotonin stimulates sex steroid
syntheses and controls the development of oogenesis, including vitellogensis in fish species
(Arcand-Hoy and Benson 2001). Serotonin was indicated to enhance the effects of
gonadotropin-releasing hormone on gonadotropin release from the pituitary gland (Khan and
Thomas 1994).
Problem
It has been apparent that these pharmaceuticals not only illicit lethality but also abnormal
behaviors that have a number of possible explanations or in some cases cannot be explained.
Nontarget organisms can experience similar effects shown in mammalian toxicity tests if they
possess the necessary target receptors and/or biomolecules present in humans and mammals
(Fent et al. 2006). Aside from the major mode of action which in most instances are fully
identified; however because pharmaceuticals have multiple secondary modes of actions,
nontarget tissues and organs can become disrupted, thus complicating the approach to quantify
possible end points.
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Despite receiving attention and necessary action by regulatory agencies like FDA and the
European Union, there is a lack for substantial procedures regarding impending monitoring of
drug concentrations in the environment and the palpable adverse effects (Rahman et al. 2007).
Published literature is minute when you take into consideration the large amount of
APIs, metabolites, and other transformation products developed and pumped into the
environment, sublethal/lethal effects that may have not occurred, the number of potential nontarget organisms (Daughton et al. 1999).
When compared to other man-made pollutants (pesticides, household and personal care
products), pharmaceuticals represent a minute portion of environmental pollutants. Aquatic
organisms are exposed to pharmaceuticals through the aforementioned pathways for their entire
life-cycle thus making them important targets. However, little is known about effects on these
organisms. Organisms that are affected on subtoxic levels effects may result in long-term
changes that may become manifested in succeeding generations of a given species in an
ecosystem (Halford 2008). Acute data alone may not be suitable for specifically addressing the
question of environmental effects and subsequently in the hazard and risk assessment (Fent
2003). A major concern is those effects which may be barely noticeable but accumulate over
time to yield extreme changes which would be masked by time and perhaps not distinguishable
from natural events. Even faint variations in routine life development have the capability to
directly or indirectly affect entire ecosystems through chain reactions originating from
disturbances in a single population or species. Upsetting the environmental balance can result in
unforeseen catastrophes through deteriorations of entire ecosystems.
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MATERIALS AND METHODS
Several single species studies using the EPA Acute Static Renewal Test (EPA-821-R-02012) (USEPA 2002) were conducted. Test organisms were exposed to six concentrations of
Ethinyl estradiol and fluoxetine for 96 hours and a control with four replications each. A total of
35 beakers were used for each single species test. Twenty four beakers housed exposed
organisms while four beakers housed controlled organisms. Seven beakers containing the fifth
replicate of concentrations were void of organisms and used for daily monitoring of water
parameters. Daily monitoring of organisms were documented daily to assess time framed doseresponses for each test organism at each concentration. The highest test concentrations were
chosen into order to induce at least 50% lethality (LC50) based on reported studies of similarly
classified organisms. After test termination, mortality curves were analyzed to quantify 96 hour
LC50s, NOECs, LOECs, and Ch.V.s for each of the five standard EPA test organisms exposed to
ethinyl estradiol and fluoxetine. Ceriodaphnia dubia (water flea), Daphnia pulex (water flea),
and Pimephales promelas (fathead minnow), which are freshwater species, and Mysidopsis bahia
(mysid shrimp) and Menidia beryllina (inland silverside) which are marine species were chosen
because currently there are no acute toxicity tests incorporating EE2 and FLX induced effects on
these standard EPA organisms. The test organisms include simple and complex aquatic species
both of freshwater and marine habitats, thus encompassing a wide spectrum of test organisms.
In addition to assessing, comparing, and contrasting mortality, this study extended
beyond lethality through the observation of sublethal effects which are not required for acute test
methods. Abnormalities observed during the test were documented and concentration
boundaries were established for sublethal effects.
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Methodology
Ethinyl estradiol (USP grade) and fluoxetine HCl (98% purity), both obtained from AK
Scientific, Inc. (Mountain View, California), were used in preparing 6 concentrations with 5
replicates (1 replicate void of organisms for water quality testing). Organisms were kept in a
controlled laboratory environment for 96 hours amid an 18/6 hour light/dark period with a light
intensity of 50-100 ft/c (REED LM-81LX Light Meter).
The immature/juvenile organisms were obtained from CK Associates Aquatic
Toxicology Laboratories (Baton Rouge, Louisiana) on the morning of test initiation and housed
in the controlled laboratory space for approximately three hours to acclimate to room
temperature which remained constant at 25 ± 1°C. Ceriodaphnia dubia, Daphnia pulex,
Pimephales promelas, Mysidopsis bahia, and Menidia beryllina were housed in borosilicate
beakers arranged in a randomized block order and covered with sleeves of Plexiglas® to prevent
external contamination.
Table 12. Age and number of test organisms deposited into the elected beaker size containing
the corresponding amount of dosing solution.
Number of
Amount of Solution
Test
Beaker Size
Age
Organisms in
in Beaker
Organism
(mL)
Container
(mL)
Ceriodaphnia dubia
< 24 hours
5
30
15
old
Daphnia pulex
< 24 hours
5
30
20
old
Pimephales promelas
1 day old
10
400
250
Mysidopsis bahia
1 day old
10
400
250
Menidia beryllina
13 days old
10
400
250

Glassware
Borosilicate glassware was used to prevent any chemicals from changing composition or
possible leaching into pores of containers which could subsequently affect test results. Prior to
test initiation, the glassware was soaked overnight in a bath of NOCHROMIX® and sulfuric
56

acid. NOCHROMIX® is a patented, white crystalline, inorganic oxidizer packaged in premeasured, hermetically sealed pouch. When mixed with sulfuric acid, it forms a clear, strong
cleaning solution. The glassware was then transferred to a deionized (DI) water bath and rinsed
with DI water to dilute and wash away residual material. After rinsing with laboratory grade
acetone, the glassware was rinsed again with DI water. They were let to air dry on clean white
contact paper.
Water Quality
Forty liters of aerated DI water was used to prepare stock solutions, concentrations, and
controls. Because Mysidopsis bahia and Menidia beryllina are marine organisms, salinity had to
be added to the DI water used for these organisms. For each 1 liter of DI water, 15 grams of
Instant Ocean® was added.
Daily monitoring of water parameters was performed in the fifth replicate of the control
(aerated DI water) and six concentrations, all void of organisms. Alkalinity (as CaCO3 in ppm)
and Hardness (ppm) were approximated colormetrically using Hach AquaCheck Dip-and-Read
Water Quality Test Strips. Temperature was taken by means of Fisher Scientific Traceable
Digital Thermometer with stainless steel probe in °C with. A certificate from ISO 17025
calibration laboratory was included and accredited by A2LA to confirm accuracy. The pH meter
used was ORION Research 230A Digital, Portal pH probe. Dissolved oxygen was measured
with OAKTON® DO 300 Waterproof Data Meter.
Dosing
Stock solutions were prepared at test initiation and 48 hour test renewal by mixing the
measured amounts of chemicals with aerated deionized water. Chemicals were left in
refrigerator and left to sit on table top for about 1 hour to remove any moisture before weighing.
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The scale was accurate to 0.000 mg. The concentrations were prepared by diluting the stock
solution by 6.5, 12.5, 25, 50, and 100% with room temperature aerated DI water.
Table 13. Test concentrations of ethinyl estradiol and fluoxetine after appropriate dilutions were
made to the measured amount used in the stock solution.
Concentration in μg/L
Amount
(parts per billion)
measured for
stock
Stock
solution
1
2
3
4
5
6
Test Organism Drug
(mg)
200
400
900
2000
4000
7000
7.010
Ceriodaphnia EE2
dubia
FLX
7
20
30
60
100
200
0.936
EE2
300
600
1000
3000
5000 10000
10.361
Daphnia
Pulex
FLX
60
100
200
500
900
1000
1.404
EE2
100
200
400
800
2000
3000
3.202
Pimephales
promelas
FLX
10
20
40
90
200
400
0.353
EE2
80
200
300
600
1000
2000
2.398
Mysidopsis
Bahia
FLX
20
50
100
200
400
800
0.760
EE2
100
200
400
800
2000
3000
3.201
Menidia
Beryllina
FLX
50
100
200
400
900
2000
1.716

Transferring organisms
Test initiation. Using 10 mL borosilicate large tip opening serological pipettes,
organisms were randomly distributed 1 at a time to differing concentrations and replicates.
Test renewal. Ceriodaphnia dubia and Daphnia pulex were transferred into clean 30 mL
beakers with the corresponding amount and concentration by using the wide tip pipette. The test
solution of Pimephales promelas, Mysidopsis bahia, and Menidia beryllina was removed with
serological pipettes until about 5 mL remained. The beakers were then refilled with fresh
solutions to bring the volume back to 250 mL.
Feeding
Test organisms were fed daily with feedings 2 hours before test initiation and 2 hours
before renewal. The required foods were also obtained from CK Associates which included a
CEROPHYLL®, a mixture of green unicellular algae and yeast, and Trout Chow for water fleas
58

and Artemia nauplii less than 24 hours old for other organisms. Before feeding regimes, Artemia
nauplii were rinsed with DI water to remove the saline solution. Excess Artemia was removed
before feeding the test organisms the next day. The excess food was gathered by pipetting the
clumps of remaining food while leaving as much solution as possible.
Table 14. Amount of standard food given to test organisms. Organisms were fed at least two
hours before test initiation and twice a day on subsequent days until test termination.
Test Organism
Food
Amount of Food
Ceriodaphnia dubia
CEROPHYLL® and Trout
0.1 mL each
Chow
Daphnia pulex
CEROPHYLL® and Trout
0.1 mL each
Chow
Pimephales promelas
Artemia nauplii
0.2 mL
Mysidopsis bahia
Artemia nauplii
0.2 mL (100 Mysid per
organism)
Menidia beryllina
Artemia nauplii
0.2 mL
Endpoints
Observations were made daily beginning with control organisms. The entire beaker was
carefully moved to a light table and all observations, lethal and sublethal, were recorded at the
time of observation.
Lethal. Deceased organisms were usually present at the bottom of the beaker and were
removed with large tip opening pipettes. Organisms floating listlessly were gently probed with
large tip opening pipettes to confirm survival. The number of surviving organisms were recorded
daily in each container and averaged within concentrations at test termination. To ensure that
toxicity of the drug not cannibalism was causing mortalities, the number of dead organisms
removed daily was also recorded.
Sublethal. During observations, any recorded abnormalities were compared to the
control and surrounding concentrations to confirm irregularities. After test termination changes
in behavior and/or abnormalities were summarized, compared, and contrasted throughout
concentrations and organisms.
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Statistical Analysis
Daily observations of survival were plotted on Dose Response Plot and analyzed using
ToxCalc5. The mortality percentages presented in the successive chapters employ the
untransformed data which are based on averages of the four replicates. The average survivorship
was transformed to Arcsine Square Roots to establish which concentrations caused survivorship
statistically different from the control. The purpose of transforming the data was to set
survivorship of the control equal to 100%. Based on Shapiro Wilk’s Test with a variance of 0.01
this transformed data was used to establish normal or non-normal distribution. If non-normal
distribution of transformed data was found or no equality of variance could be determined, the
hypothesis test used was Steel’s Many One Rank Test with a 0.05 variance. This hypothesis test
determined the no observable effect concentration (NOEC), lowest observable effect
concentration (LOEC), and the chronic value (Ch.V.) based on survivorship. The ChV. is the
determined from a ratio of the NOEC and LOEC and is presumed ―safe.‖ It should be lower
than the EC50. Based on the definition of the chronic value the EC50 is usually slightly higher
than Ch.V.
To establish the dose-response curve, the Maximum Likelihood-Probit Method was used
to determine the Effective Concentration (ECx) with upper and lower 95% fiducial limits when
applicable. The fiducial limits are the boundaries within which a parameter is considered to be
located. In this case the EC represents the effective concentration of the desired percent
mortality (x). In a normal dose-response curve, the y-axis is usually the mortality response and
the x-axis is the dose of the drug. As the dose increases the effect should increase. Hormetic
responses show an opposite effect in small doses compared to large doses. The lower doses
stimulate more lethal effects than the higher doses. The result is a J-shaped or an Inverted Ushaped dose response curve.
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RESULTS
Lethal Effects
Daily observations of survival were documented to assess the time framed doseresponses for each test organism at each concentration. The dose-response curve was used to
quantify the effective concentration at which an average of 50% of test organisms encountered
lethal effects (EC50 or LC50). The upper and lower 95% fiducial limits were the applicable
boundaries within which the ECx was considered to be located. The y-axis of the dose-response
curve was the response, the percent mortality, caused by the dose of the drug which is
represented in the x-axis. A normal dose-response curve resembles an S-shape; this implies that
as the dose or concentration increases, so should the response. The opposite effect in which
lethal effects were induced by lower concentrations resulted in a J-shaped or an Inverted Ushaped dose response curve and categorized as a hormetic response.
After test termination, lethal effects to ethinyl estradiol (Table 15) and fluoxetine (Table
16) were documented as percent mortality which incorporates the average untransformed
lethality of test organisms caused after 96 hours of exposure. Derived from the transformed data
were the statistically significant concentrations, the NOECs, and the LOECs. The chronic value
was statistically elected from the NOEC/LOEC ratio. By definition, this concentration is not
considered to be harmful thus it should be lower than the EC50.
Lethal Effects of Ethinyl Estradiol to Ceriodaphnia dubia
The normal dose-response of Ceriodaphnia dubia exposed to 200 – 7000 ppb of ethinyl
estradiol yielded an EC50 of 400 ppb which had 95% fiducial limits of 400 and 300 ppb (Figure
1). Based on the 20 organisms allotted for each of the concentrations, the average mortality was
compared to the control (0% mortality). The only concentration not statistically significant when
compared to the control was the NOEC, 200 ppb, which only had 20% mortality. Statistically
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significant figures included the LOEC, 400 ppb, which had 60% mortality, and 900, 2000, 4000,
and 7000 ppb all bared 100% mortality (Table 15). The chronic value, 300 ppb, was only slightly
lower than the EC50.
Ceriodaphnia dubia Dose-Response Curve
1
0.9
0.8

Lethality

0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
10

100

1000

10000

EE2 (ug/L)
Figure 1. The Ceriodaphnia dubia dose-response curve and 95% fiducal limits derived from the
average mortality of four replications caused by 96 hours of exposure to 200 – 7000 ppb of
Ethinyl estradiol. The EC50 of 400 ppb had 95% fiducial limits of 400 and 300 ppb when
compared to 0 because no mortality was observed in the control.
Lethal Effects of Ethinyl Estradiol to Daphnia pulex
The dose-response of Daphnia pulex after 96 hours of exposure to ethinyl estradiol
concentrations of 300 -10000 ppb, the EC50, 6000 ppb, with limits of 5000 and 8000 ppb
resulted from the control of 0.1 (Figure 2). Due to 10% mortality in the control the statistically
insignificant concentrations included the NOEC, 3000 ppb, (20% mortality) as well as the lesser
concentrations which exhibited a hormetic curve: 300 (25%), 600 (5%), and 1000 ppb (30%).
Significantly different concentrations included the LOEC, 5000 ppb, which caused 40%
mortality and 10000 ppb triggered 95% mortality (Table 15). The Ch.V., 4000 ppb, was based
on a ratio of the NOEC and the LOEC.
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Daphnia pulex Dose-Response Curve
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Figure 2. The Daphnia pulex dose-response curve and 95% fiducal limits derived from the
average mortality of four replications caused by 96 hours of exposure to 300 -10000 ppb of
ethinyl estradiol. The EC50 of 6000 ppb had 95% fiducial limits of 5000 and 8000 ppb when
compared to 0.1 because 10% mortality was observed in the control.
Lethal Effects of Ethinyl Estradiol to Pimephales promelas
The normal dose-response of Pimephales promelas exposed to 100 –3000 ppb of EE2
resulting in the anticipated EC50 of 11000 ppb. No fiducial limits were determined; however, a
significant heterogeneity was detected at p = 3.87 x 10-4 (Figure 3). The dose response plot
exhibited a bell curve with disruption in the plot at the following insignificant values compared
to the control (0% mortality): 100 (5%), 200 (3%), 400 (0%), and 800 ppb (3%). The NOEC,
2000 ppb, ended with only 8% mortality. The only significantly different concentration was the
LOEC, 3000 ppb, which was highest concentration. Because this level only yielded 40%
mortality (Table 15), the resulting Ch.V. was 2000 ppb.

Lethal Effects of Ethinyl Estradiol to Mysidopsis bahia
The normal dose-response of Mysidopsis bahia exposed to 80 – 2000 ppb had an EC50
was 400 ppb with a large range of fiducial limits, 40 - 2000 ppb with control 0.075 (Figure 4).
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Pimephales promelas Dose-Response Curve
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Figure 3. The Pimephales promelas dose-response curve derived from the average mortality of
four replications caused by 96 hours of exposure to 100 –3000 ppb of ethinyl estradiol. The
EC50 of 11000 ppb had no fiducial limits when compared 0 because no mortality was observed
in the control. Given that a non-normal response was created a significant heterogeneity was
detected at p = 3.87 x 10-4.
Dose-Response Curve of Mysidopsis bahia
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Figure 4. The Mysidopsis bahia dose-response curve and and 95% fiducal limits derived from
the average mortality of four replications caused by 96 hours of exposure to 80 – 2000 ppb of
ethinyl estradiol. The EC50 of 400 ppb had 95% fiducial limits of 40 - 2000 ppb when
compared to 0.075 because 7.5% mortality was observed in the control.
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Mortality remained fairly constant from control – 300 ppb (5-7% mortality); however, organisms
exposed to 80 ppb faced less mortality than control. The NOEC, 300 ppb, and 200 ppb
experienced identical changes in mortality of about 13%. At the LOEC, 600 ppb, mortality
plummeted to about 68% assigning a Ch.V. of 400 ppb.

Significantly different concentrations

of 1000 and 2000 ppb suffered about 95-100% mortality respectively (Table 15).
Lethal Effects of Ethinyl Estradiol to Menidia beryllina
The normal dose-response of Menidia beryllina exposed to 100 – 3000 ppb caused the
EC50, 2000 ppb, with fiducial limits of 1000 and 2000 ppb, which was compared to 0.025 due to
mortality in the control (Figure 5). A slight hormetic effect was observed in concentrations less
than 400 ppb rendering them insignificant. The control and 200 ppb organisms experienced
about 2.5% mortality while 100 ppb had 5% and 400 ppb had 0% mortality. Additionally the
NOEC, 800 ppb, was also insignificant affecting about 13%.
Dose-Response Curve of Menidia beryllina
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Figure 5. The Menidia beryllina dose-response curve and 95% fiducal limits derived from the
average mortality of four replications caused by 96 hours of exposure to 100 – 3000 ppb of
ethinyl estradiol. The EC50 of 2000 ppb had 95% fiducial limits of 1000 and 2000 ppb, when
compared to 0.025 because 2.5%.mortality was observed the control.
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The higher concentrations including the LOEC, 2000, (about 43%) and 3000 ppb (100%) were
significantly different than the control (Table 15). A Ch.V. of 1000 ppb was prompted.
Table 15. Untransformed data presented as the average percent mortality caused after 96 hours
of exposure to ethinyl estradiol including the statistically derived concentrations, the NOEC, and
the LOEC associated with each single species test.
Ethinyl estradiol Concentration vs. Mortality
C. dubia
D. pulex
P. promelas
M. bahia
M. beryllina
Dose
(ppb)

Mortality
(%)

Dose
(ppb)

Mortality
(%)

Dose
(ppb)

Mortality
(%)

Dose
(ppb)

Mortality
(%)

Dose
(ppb)

Mortality
(%)

Control
0
200
NOEC
*400
LOEC

0

Control
0

10

Control
0

0

Control
0

6.67

Control
0

2.5

20

300

25

100

5

80

5.28

100

5

60

600

5

200

2.5

2000

5

200

2.5

*900

100

1000

30

400

0

8.06

400

0

*2000

100

20

800

2.5

*4000

100

*7000

100

3000
NOEC
*5000
LOEC
*10000

40
95

2000
NOEC
*3000
LOEC

300
NOEC
*600
LOEC

53.17

7.5

*1000

93.75

40

*2000

100

800
NOEC
*2000
LOEC
*3000

12.5
42.5
100

*Statistically significant concentrations were derived using TOXCALC 5 by transforming the
average survivorship to Arcsine Square Roots. Based on the Shapiro Wilk’s Test with a variance
of 0.01 this transformed data was used to determine statistically significant concentrations.
NOECs and LOECs were established using Steel’s Many One Rank Test with a 0.05 variance.
Lethal Effects of Fluoxetine to Ceriodaphnia dubia
The non-normal dose-response of Ceriodaphnia dubia exposed to 7 – 200 ppb contained
no fiducial limits to the assigned EC50 of 5 ppb, but a significant heterogeneity was detected at
p = 2.68E-10. Control was 0.1 due to mortality in the control (Figure 6). Concentrations not
significant from the control (10%) included 7 ppb which had 25% mortality and the NOEC, 100
ppb, (60%). Median concentrations of 20, 30, and 60 ppb triggered 100% mortality at the end of
96 hours and made them significantly different than the control. The highest concentration was
deemed the LOEC, 200 ppb, which stimulated 95% mortality. Because of the decrease in
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mortality at the NOEC, the LOEC was not the first significant figure. The Ch.V. of 200 ppb was
based on this effect (Table 16).

Ceriodaphnia dubia Dose Response Curve
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Figure 6. Ceriodaphnia dubia dose-response curve derived from the average mortality of four
replications caused by 96 hours of exposure to 7 – 200 ppb of fluoxetine. The EC50 of 5 ppb
had no 95% fiducial limits when compared to 0.1 because 10% mortality was observed the
control. Given that a non-normal response was created a significant heterogeneity was detected
at p = 2.68 x 10-10.

Lethal Effects of Fluoxetine to Daphnia pulex
The normal dose-response of Daphnia pulex exposed to 60 – 1000 ppb The EC50, 200
ppb, with upper and lower 95% fiducial limits of 300 and 100 ppb were compared to a control of
0.1 (Figure 7). The control and 100 ppb retained 10% mortality while the median concentration,
60 ppb, gained 15% mortality. These concentrations along with the NOEC, 200 ppb, (80%)
remained insignificant. The LOEC, 500 ppb, which lead to 90% mortality, and 900 and 1000
ppb both with 100% mortality were all significantly different than the control (Table 16). The
Ch.V. was determined to be 300 ppb.
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Daphnia pulex Dose Response Curve
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Figure 7. The Daphnia pulex dose-response curve and 95% fiducal limits derived from the
average mortality of four replications caused by 96 hours of exposure to 60 – 1000 ppb of
fluoxetine. The EC50 of 200 ppb had 95% fiducial limits of 300 and 100 ppb when compared to
0.1 because 10% mortality was observed the control.
Lethal Effects of Fluoxetine to Pimephales promelas
The dose-response of Pimephales promelas Exposed to 10 – 400 ppb The EC50 was 200 ppb
with an upper limit of 200 and a lower limit of 200 ppb (Figure 8). The control together with the
lesser concentrations of 10, 20, and 40 ppb, all yielded 0% mortality which scored them as
insignificant. The NOEC, 90 ppb, concluded in only 3% mortality. The two concentrations
statistically different than the control included the LOEC, 200 ppb, which caused a 40% change
and 400 ppb which affected 100% of the organisms (Table 16). The Ch.V. transpired as 100
ppb.
Lethal Effects of Fluoxetine to Mysidopsis bahia
The non-normal dose-response of Menidia beryllina exposed to 20 – 800 ppb EC50 was
500 ppb with no limits available established a significant heterogeneity of p = 2.96 x 10-3 (Figure
9).
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Pimephales promelas Dose Response Curve
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Figure 8. The Pimephales promelas dose-response curve and 95% fiducal limits derived from the
average mortality of four replications caused by 96 hours of exposure to 10 – 400 ppb of
fluoxetine. The EC50 of 200 ppb had 95% fiducial limits of about 200 ppb when compared to 0
because no mortality was observed the control.
Mysidopsis bahia Dose Response Curve
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Figure 9. The Mysidopsis bahia dose-response curve derived from the average mortality of four
replications caused by 96 hours of exposure to 20 – 800 ppb of fluoxetine. The EC50 of 500 ppb
had no 95% fiducial limits when compared 0 because no mortality was observed in the control.
Given that a non-normal response was created a significant heterogeneity was detected at
p = 2.96 x 10-3.
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There was an immense decrease in mortality at 20 ppb (40%) when compared to the next highest
concentration of 50 ppb, the NOEC, (13%). This NOEC was the only concentration not
significantly different from control (0% mortality). A hormetic effect occurred between
concentrations 100, the LOEC, and 400 ppb. Mortality decreased from 47.5% - 35%. Increased
mortality was observed at the next highest concentration, 800 ppb (62.5%). The Ch.V. was 70
ppb because the NOEC exhibited a lower mortality than lesser concentrations (Table 16).
Lethal Effects of Fluoxetine to Menidia beryllina
The dose-response of Menidia beryllina exposed to 50 – 2000 ppb EC50, 500 ppb, with
upper and lower limits of 500 and 600 ppb. The control for comparison was 0.025 (Figure 10).

Menidia beryllina Dose Response Curve
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Figure 10. The Menidia beryllina dose-response curve and 95% fiducal limits derived from the
average mortality of four replications caused by 96 hours of exposure to 50 – 2000 ppb of
fluoxetine. The EC50 of 500 ppb had 95% fiducial limits of 500 and 600 ppb when compared to
0.025 because 2.5% mortality was observed the control.

Concentrations not significantly different than the control (about 3%) included 50 ppb (about
13%) and the NOEC, 200 ppb, (20%); however, 100 ppb also had 20% mortality but was
considered significant. Remaining concentrations were also regarded as significant. Compared
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to the LOEC, 400 ppb, which caused 35% mortality, exposure to 900 ppb caused a severe incline
in mortality (about 93%) along the highest concentration of 2000 ppb (100%) (Table 16). The
Ch.V. of 300 ppb was less than EC50, 500 ppb.

Table 16. Untransformed data presented as the average percent mortality caused after 96 hours
of exposure to fluoxetine including the statistically derived concentrations, the NOEC, and the
LOEC associated with each single species test.
Fluoxetine Concentration vs. Mortality
C. dubia
D. pulex
P. promelas
M. bahia
M. beryllina
Dose
(ppb)

Control
0
7

Mortality
(%)

Dose
(ppb)

25

Control
0
60

*20

100

100

*30

100

*60

100

100
NOEC
*200
LOEC

10

200
NOEC
*500
LOEC

Mortality
(%)

Dose
(ppb)

Mortality
(%)

15

Control
0
10

10

20

0

80

40

0

10

90

60

*900

100

95

*1000

100

0
0

90
NOEC
*200
LOEC
*400

Dose
(ppb)

Control
0
*20
50
NOEC
*100
LOEC

Mortality
(%)

Dose
(ppb)

Mortality
(%)

40

Control
0
50

12.5

12.5

*100

20

0

47.5

2.5

200
NOEC
*400
LOEC

20

2.5

*200

45

35

40

*400

35

*900

92.5

100

*800

62.5

*2000

100

*Statistically significant concentrations were derived using TOXCALC 5 by transforming the
average survivorship to Arcsine Square Roots. Based on the Shapiro Wilk’s Test with a variance
of 0.01 this transformed data was used to determine statistically significant concentrations.
NOECs and LOECs were established using Steel’s Many One Rank Test with a 0.05 variance.
Sublethal Effects
Because the environmental amounts are below those to stimulate mortality these results
of this study extend beyond lethality through the observation of sublethal effects which are not
required for acute test methods. In addition to high toxicity potential these two pharmaceuticals
are extremely potent in controlling hormonal, serotonergic, and dopaminergic systems in
mammals/humans which could interfere with key biological functions including but not limited
to fecundity, growth and development, and behavior in nontarget organisms. Organisms are
exposed for entire life cycles in environmental settings. In the current study juvenile organisms
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were exposed during an important life stage of growth and development. Any changes could be
important to note because they were occurring within 96 hours.
Sublethal Effects of Ethinyl Estradiol
Ceriodaphnia dubia decreased activity as time and concentration increased. At the end of
96 hours the C. dubia exposed to 200 ppb, the NOEC, had 1 larval offspring in each container;
additionally, deceased organisms observed in microscopic photos had larvae in the brood
chamber. The number of offspring ranged from 1-7 for organisms exposed to 400 ppb, the
LOEC.
Daphnia pulex exposed to 300 ppb became lethargic and lifeless after 72 hours exposure.
Those granted 300 and 1000 ppb for 24 hours began swimming around the parameter of the
beaker. At 72 hours in 5000 ppb, organisms crashed into the sides of the beakers and attempted
escape. Eggs were first observed on the tails of D. pulex at 24 hours in 10000 ppb. At 72 hours
in 1000 ppb. D. pulex appeared to have eggs in the brood chamber and looked much larger by
comparison. Offspring were observed in 600 and 3000 ppb. At test termination, ephippia were
present at the base of the beaker in concentrations greater than 3000 ppb. Ephippia are fertilized
resting eggs encased in a tough covering to withstand extreme conditions. These ―winter eggs‖
are released by the female under times of stress and rest at the bottom of a water body until
favorable conditions return. At 72 hours, organisms in 300 ppb were missing. In concentrations
300 and 1000 ppb at the end of 96 hours, dead daphnia appeared to have been eaten by survivors.
Prior to test renewal in 10000 ppb, the water appeared cloudy possibly from algae dying.
Pimephales promelas exposed to EE2 decreased general activity as time and
concentration increased. Most of the minnows in 400 – 3000 ppb became extremely lethargic as
time increased. However, during the first 24 hours, organisms in 800 ppb became frantic. Few
swim abnormalities were observed in 400 and 2000 ppb; the organisms began swimming
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inconsistently throughout the water column and jumpy and became disoriented for the entire test.
At concentrations above 800 ppb the organisms remained quite drab in color. During the first
few days of the test, roughly 2-5 minnows yielded aggressive and probing actions at 800 and
2000 ppb. Those administered 800 ppb ceased aggressive activity as time increased; on the other
hand organisms in 2000 ppb continued this behavior for duration of the test. In 100 and 200 ppb
deceased minnows appeared damaged and mutilated by the remainders. The underbelly of a
minnow in 3000 ppb appeared injured. Interestingly, this concentration triggered an enormous
engorgement of swim bladders. Upon microscopic investigation is was shown that swim bladder
size increased in a dose dependent manner.
Mysidopsis bahia displayed aggressive behaviors in 1000 ppb at 24 hours and 80 ppb at
72 hours. Hostility was delayed in lesser concentrations but in higher concentrations this activity
decreased with time. In concentrations 300 ppb and below, cannibalism decreased as
concentrations increased. Cannibalism ceased after 24 hours in concentrations above 600 ppb.
Feeding decreased at concentrations 1000-2000 ppb; however, the artemia, were alive and very
active. The food source appeared to much more active in concentration 2000 ppb but were
motionless after one day. Mysid subjected to 200 ppb were noticeably larger and darker after 72
hours observation. Similarly, denser coloration was observed in all unexposed organisms and
sporadically throughout lesser concentrations; however, those subjected to EE2 were more
massive.
Menidia beryllina became motionless after 72 hours of exposure which became more
appreciated in elevated concentrations. In 400 ppb fish exhibited extremely restless behavior that
decreased with time. Swim abnormalities of organisms in 2000 ppb were observed at 48 hours in
which they began flipping backwards. Throughout the test the number of organisms that
experienced tremors in 2000 and 3000 ppb correlated with lethality. For example, in the highest
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test concentration, the organisms began seizing at 24 hours and the next day suffered 100%
mortality. Accelerated maturation was observed in those exposed to 100-200 ppb by evidence of
pigmentation at the head. One organism in 2000 ppb had a yellow body with a clear tail which
supposedly occurs when they reach maturity. Engorged abdomens developed at 48 hours in 200400 ppb.
Sublethal Effects of Fluoxetine
Ceriodaphnia dubia began lifelessly floating on edge of the beaker at 20 – 200 ppb. For
the entirety of the test, organisms in 7 ppb were very active and anxious; this concentration
caused organisms to increase in size compared to the control or elevated concentrations.
Daphnia pulex in 200 ppb at became immobilized after 48 hours. At concentrations
above 500 ppb, the majority of organisms remained lethargic throughout the entirety of the test.
Abnormal swim behaviors were observed at 48 hours in 60 ppb in which the daphnia exhibited
extremely jerky swimming motions. Throughout the test, organisms in this concentration
appeared to be combating and/or mating; however, neither eggs nor offspring were detected. In
100 ppb at test termination, organisms appeared to be rotating backwards and swimming in
circles around beaker. Daphnia appeared to increase size in 900 and 1000 ppb. In the lesser
concentrations, abdomens were distended.
Pimephales promelas were floating listlessly on the surface of the water table;
nonresponsiveness became more appreciated as concentration and time increased. In 20 - 40
ppb minnows displayed stationary vertical positioning. A small number of minnows in 10 – 90
ppb appeared disoriented; however this activity decreased as time and concentration increased.
Restless behavior decreased as concentration and time increased. At test termination fathead
minnows in 90 – 200 ppb became aggressive by probing the inactive organisms at the surface.
Interestingly enough, organisms in these concentrations had crooked spines and began swimming
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in corkscrew motion. The spine curvature was confirmed by microscopic observation;
additionally confirmed were the larger and lighter swim bladders of exposed organisms.
Mysidopsis bahia exposed to FLX displayed very little activity; however, those in 190
ppb were larger and more active than mysid in 100, 400, and 800 ppb. These later
concentrations triggered abnormal behaviors. At 24 hours organisms in 800 ppb executed
tumbling behaviors. Those in 100 ppb exhibited this same behavior at 48 hours but were
inflicted with crooked tails. Organisms exposed to concentrations above 200 ppb, exhibited
decreased feeding and pigmentation. During the first 24 hours, cannibalism was observed in all
concentrations of FLX except 50 ppb, the NOEC. As concentrations increased, casualties due to
cannibalism decreased in response to the decrease in antagonistic behavior
Menidia beryllina exposed to lower concentrations were hovering at the surface showing
very little activity. During first 24 hours, organisms in higher concentrations exhibited fits of
agitation. After test renewal, immobilization increased with time and concentration; at test
termination all exposed organisms were lethargic. In addition, prior to 48 hour test renewal,
catatonic behavior and vertical positioning was more prominent in all organisms as time and
concentration increased. Exposure to 900 and 2000 ppb convulsing and seizing; CNS toxicity
correlated with fatality. Few fish suffered inflamed abdomens.
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DISCUSSION
Because the basis of the study rested on the hypothesis that similarly classified organisms
would exhibit similar responses in mortality, the organisms’ responses were compared and
contrasted against different levels: dose-response plots, the percent mortality detected at a
median concentration, the lowest concentration that induced 100% mortality, the median
effective concentration based on lethality (EC50 or LC50), and the chronic value derived from a
ratio of the no observable concentrations and the lowest observable effect concentrations based
on mortality. After test termination, mortality curves were analyzed to quantify 96 hour LC50s,
NOECs, LOECs, and Ch.V.s for each of exposed to ethinyl estradiol and fluoxetine.
Lethal Effects Based on Dose-Response Plot
To compare and contrast the dose induced mortality, the average untransformed percent
mortality were plotted against the test concentration with the NOECs and LOECs identified in
ethinyl estradiol (Figure 11) and fluoxetine (Figure 13). A normal response should correlate with
the dose and form a straight line. This was observed in dose-response plots of C. dubia exposed
to ethinyl estradiol (Figure 11) and in D. pulex, P. promelas, and M. beryllina exposed to
fluoxetine (Figure 13).
A hormetic response or a disruption in the linear dose-response correspondence was
observed in D. pulex, P. promelas, M. bahia, and M. beryllina exposed to EE2 (Figure 11) and in
C. dubia and M. bahia exposed to FLX (Figure 13).
Dose-response plot effects of ethinyl estradiol. C. dubia exhibited a normal dose
response with concentrations above 900 ppb exhibiting 100% mortality. A disruption in the dose
response plot for D. pulex showed a decrease in mortality in concentrations 600 and 3000 ppb. P.
promelas, M. bahia, M. beryllina exhibited hormetic response. D. pulex exhibited a similar
curve but the disruption in the curve is different. A significant decrease in mortality from the
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NOEC to the LOEC was observed in C. dubia and M. bahia producing similar EC50 and chronic
values around 300 - 400 ppb. At 3000 ppb M. beryllina had 100% mortality while P. promelas
had only 40% mortality making it very resilient. Interestingly at the lesser concentrations, 100 800 ppb both fish exhibited identical hormetic changes in mortality (Figure 11).
Effects of Ethinyl estradiol on Mortality
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Figure 11. The observed percent mortality and the analyzed NOEC and LOEC determined at test
termination for all test organisms exposed to test concentrations of ethinyl estradiol.
Dose-response plot effects of fluoxetine. In concentrations 20 – 200 ppb C. dubia
exhibited a hormetic effect at 48 hours and produced about 100% mortality at test termination.
A disruption in the dose-response curve in 100 ppb (about 60%) could explain why the chronic
value is higher than EC50. D. pulex had a normal dose response curve with the NOEC of 200
ppb manifesting 80% mortality. P. promelas had little or no mortality from 0 - 90 ppb and
exhibited a normal response not including the drastic increase in mortality (3 – 100%) which
occurred in 90 – 400 ppb. M. bahia exhibited a slight hormetic change at 100 – 400 ppb (47.5 –
35%) and reduction in mortality at 50 ppb (NOEC, the only non significant concentration)
rendering the second significant concentration as the LOEC. M. beryllina depicted a normal
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dose response curve with very little change between first three concentrations (50, 100, 200 ppb)
with a dire variation in mortality after LOEC of 400. Aside from a slight hormetic change, D.
pulex and M. beryllina exhibited normal dose response curves. P. promelas demonstrated this
normalcy apart from the radical increase in mortality (3 – 100%) from 800 – 3000 ppb (Figure
12).
Effects of Fluoxetine on Mortality
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Figure 12. The observed percent mortality and the analyzed NOEC and LOEC determined at test
termination for all test organisms exposed to test concentrations of fluoxetine.

Lethal effects based on Median Concentrations and Concentrations Causing Complete
Mortality
The effects on mortality were projected to be comparable to similarly cataloged
organisms. The concentrations needed to induce mortality were expected to be smaller in
crustaceans Ceriodaphnia dubia (water flea), Daphnia pulex (water flea), and Mysidopsis bahia
(mysid shrimp) because they are simpler organisms with shorter life cycles, making them more
susceptible and vulnerable to the toxicants. Because fish are more complex organisms with more
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intricate bodily functions and longer life cycles the Pimephales promelas (fathead minnow) and
Menidia beryllina (inland silverside) were expected to be more resilient to these drugs.
Mortality based on Median Concentrations
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Figure 13. A comparison of the percent mortality in all species of test organisms caused after 96
hours of exposure to the median concentrations 2000 ppb of ethinyl estradiol and 100 ppb of
fluoxetine.
Median concentrations of ethinyl estradiol. Based on an EE2 concentration of 2000
ppb, P. promelas had 8% mortality, D. pulex (30-20%), M. beryllina (42.5%), M. bahia (95100%) and C. dubia (100%).
Median concentrations of fluoxetine. At a concentration of 100 ppb FLX mortalities
were recorded as D. pulex (10%), P. promelas (3-40%), M. beryllina (20%), M. bahia (47.5 –
45%), and C. dubia (60%).
Complete mortality in ethinyl estradiol. The lowest concentrations of EE2 causing
100% mortality were as follows: C. dubia (900 ppb), M. bahia (2000 ppb), M. beryllina (3000
ppb), P. promelas (8000 ppb), and D. pulex (10000 ppb).
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Complete mortality in fluoxetine. The lowest concentration causing 100% were as
follows: C. dubia (20 ppb), P. promelas (400 ppb), D. pulex (900 ppb), M. bahia (1000 ppb), and
M. beryllina (2000 ppb).
Lowest Concentration Producing 100% Mortality
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Figure 14. A comparison of the lowest concentrations of ethinyl estradiol and fluoxetine
producing 100% mortality in all species of test organisms.
Median Effective Concentrations Causing Lethality
The lethal concentrations (LC50s) were expected to be smaller in the crustaceans than in
the fish. The highest test concentrations were chosen into order to induce at least 50% lethality
(LC50) based on literature review of similarly classified organisms (EE2, Table 1; FLX, Table
5). Quantified 96 hour LC50s were established for the five test organisms and were compared
against literature review.
Ethinyl estradiol EC50s The most sensitive species based on EC50: C. dubia (400 ppb)
> M. bahia (600 ppb) > M. beryllina (2000 ppb) > D. pulex (6000 ppb) > P. promelas (10000
ppb).
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Similarly classified organisms – crustaceans The three crustaceans produced the
following 96 hour LC50s after exposure to EE2: Ceriodaphnia dubia (water flea) (400 ppb) >
Mysidopsis bahia (mysid shrimp) (600 ppb) > Daphnia pulex (water flea) (6000 ppb).
Compared to the similarly classified test organisms, the Nitocra spinipes (harpacticoid
copepod), a crustacean whose habitat ranges from fresh water to hypersaline conditions,
displayed an increase in mortality yielding a 96 hour LC50 of 500 ppb (Breitholtz and Bengtsson
2001) which was between the quantified LC50s of the two crustaceans, C. dubia (400 ppb) and
M. bahia (600 ppb), while being significantly lower than the D. pulex.
The marine shrimp, Neomysis integer (opossum shrimp) showed an increase in mortality
at 1000 ppb (Verslycke et al. 2004). The M. bahia is also a marine shrimp but yielded a much
lower LC50 (600 ppb).
Watts et al. (2001) showed that the Gammarus pulex (scud) displayed an increase in
mortality at 2000 ppb. This freshwater shrimp exhibited an LC50 between that of the M. bahia
(600 ppb) and the D. pulex (6000 ppb). Interestingly this freshwater shrimp had a 96-hour LC50
identical the marine fish, the M. beryllina (2000 ppb).
Similarly classified organisms – fish. The two fish species produced the following 96
hour LC50s after exposure to EE2: Menidia beryllina (inland silverside) (2000 ppb) >
Pimephales promelas (fathead minnow) (10000 ppb).
Versonnen et al. (2003) showed that Danio rerio (zebrafish), a tropical freshwater fish
belonging to the minnow family, caused an LC50 of 2000 ppb. This 96 hour LC50 is identical to
the marine fish M. beryllina (2000 ppb) but much lower than the freshwater minnow (10000
ppb).
Fluoxetine EC50s. The most sensitive species based on EC50: C. dubia (5 ppb) > P.
promelas (200 ppb) > D. pulex (200 ppb) > M. bahia (500 ppb) > M. beryllina (500 ppb).
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The hypothesis was that similarly classified organisms would have close to the same LC50s.
Similarly classified organisms – crustaceans. The three crustaceans produced the
following 96 hour LC50s after exposure to FLX: Ceriodaphnia dubia (water flea) (5 ppb) >
Daphnia pulex (water flea) (200 ppb) > Mysidopsis bahia (mysid shrimp) (500 ppb).
Brooks et al. (2003b) found that Ceriodaphnia dubia produced an LC50 of 300 ppb.
This concentration is close to the other species of water flea, the D. pulex (200 ppb) and the
freshwater fish the P. promelas (200 ppb). While still close to the other crustacean, M. bahia
(500 ppb), the exact same species was much lower than the literature review due to the observed
hormetic effects.
Brooks et al. (2003b) also documented the LC50 in another species of water flea,
Daphnia magna, as 900 ppb. This concentration was much higher than any of the determined
LC50s of the test species used in the current study.
Similarly classified organisms – fish. The two fish species produced the following 96
hour LC50s after exposure to FLX: Pimephales promelas (fathead minnow) (200 ppb) >
Menidia beryllina (inland silverside) (500 ppb).
Brooks et al. (2003b) documented the LC50 of Pimephales promelas (fathead minnow)
as 800 ppb. In the current study, all test organisms had 96 hour EC50s much lower than this
concentration. The concentration 400 ppb caused 100% mortality in P. promelas. According to
the raw data, M. beryllina experienced 35% mortality at 400 ppb which increased to about 93%
at 900 ppb. Interestingly, at 800 ppb the crustacean, M. bahia suffered around 63% mortality.
Winder et al. (2009) found that Cyprinodon variegatus (sheepshead minnow) a
marine/brackish water fish only caused 47% mortality in 2000 ppb. In the current study, the
highest LC50 was 500 ppb in the M. beryllina (inland silverside) with a documented 100%
mortality observed at 2000 ppb.
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The fish species Oryzias latipes (Japanese medaka) had a 96 hour LC50 of 2000 ppb (Eli
Lilly and Company 2005). The highest concentration used in the current study of M. beryllina
was 2000 ppb which caused 100% mortality. The concentration that caused 100% mortality in
P. promelas was 400 ppb.
Nakamura et al. (2008) documented the LC50s of Oryzias latipes (Japanese medaka) as
6000 at a pH of 7, 1000 at a pH of 8, and 200 at a pH of 9. In the current study, all test organisms
had 96 hour LC50s much lower than those found at pHs 7 and 8; however, the LC50 at the pH of
9 (200 ppb) was identical to the fish P. promelas (200 ppb) and the water flea D. pulex (200 ppb)
and comparable to the fish M. beryllina (500 ppb) and the shrimp M. bahia (500 ppb).
Chronic Values
The chronic value was statistically elected from the NOEC - LOEC ratio according to the
Steel’s Many One Rank Hypothesis Test. By definition, this concentration is not considered to
be harmful thus it should be lower than the EC50.
Ethinyl estradiol chronic values. The most sensitive species based on Ch.V: C. dubia
(300 ppb) > M. bahia (400 ppb) > M. beryllina (1000 ppb) > P. promelas (2000 ppb) > D. pulex
(4000 ppb).
All test organisms exposed to EE2 follow the idea that the EC50 is usually slightly higher
than Ch.V. (Figure 15). In C. dubia and M. bahia the EC50 was only slightly higher than the
Ch.V. in consequence of the normal dose response curve as well as the NOECs causing more
than 20% mortality LOECs causing about60-68% mortality and the highest concentrations
bringing about 100% mortality. The EC50 of P. promelas is more sizable than the Ch.V.
attributable to only 40% mortality occurring in the LOEC which was the highest concentration
and only 8% mortality in the NOEC. The LOEC D. pulex also produced 40% mortality
formulating an EC50 more considerable than the Ch.V. Additionally, a hormetic response was
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observed from the lowest concentration throughout the NOEC. The EC50 of M. beryllina was
fairly larger than the Ch.V. because the LOEC had 43% with next highest concentration
producing 100%.
Ethinyl estradiol
EC50 and Chronic Value
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Figure 15. A comparison of the statistically analyzed EC50s and chronic values of organisms
after 96 hours of exposure to ethinyl estradiol.
Fluoxetine chronic values. All the Ch.V.s were pretty close ranging from 70-300 ppb.
The most sensitive Ch.V: M. bahia (70 ppb) > P. promelas (100 ppb) > C. dubia (200 ppb) > D.
pulex (200 ppb) > M. beryllina (300 ppb).
Based on the definition of the chronic value the EC50 is usually slightly higher than
Ch.V. (Figure 16). The EC50 is lower than Ch.V. in C. dubia because there was 100% mortality
in concentrations less than the NOEC (60%) and LOEC (95%). Additionally, in D. pulex, there
was 80% in the NOEC and 90% in the LOEC and 10-15% in control and lesser concentrations.
In P. promelas the EC50 was greater than the Ch.V. despite the drastic change in mortality
between the three highest concentrations which included the NOEC and the LOEC, which only
caused 40% mortality. The much higher EC50s in M. bahia and M. beryllina for can be
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attributed to the disruption in the normal dose-response curve and because the LOEC is not the
first significantly different concentration.
Fluoxetine
EC50 and Chronic Value
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Figure 16. A comparison of the statistically analyzed EC50s and chronic values of organisms
after 96 hours of exposure to fluoxetine.
Classification of Lethal Effects
Dose-response relationships are usually very well documented in the intended target of
the pharmaceutical (i.e. humans or target animals). However, the uncertainty with nontarget
organisms is great due to changes in dosage, exposure time, response, pharmacokinetic action,
and external interferences (O’Conner et al. 2002). Based on classification by Annex VI to the
European Community legislation (Directive 67/548/EEC) pharmaceuticals can be categorized by
the expected toxicity on the ecosystem based on LC50, log Kow, and solubility in water.
R50: ―Very toxic to aquatic organisms.‖ – Acute toxicity [LC50 (fish) or EC50 (daphnia)] ≤
1000 ppb.
R50 and R53: ―Very toxic to aquatic organisms and may cause long-term adverse effects in the
aquatic environment.‖
– Acute toxicity ≤ 1000 ppb, and the compound is not readily degradable, or log Kow ≥ 3
(unless experimentally derived BCF ≤100).
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R51: ―Toxic to aquatic organisms.‖
– Acute toxicity > 1000 ppb and ≤ 10000 ppb.
R51 and 53: ―Toxic to aquatic organisms and may cause long-term adverse effects in the aquatic
environment.‖
– Acute toxicity > 1000 ppb and ≤ 10000 ppb and the compound is not readily
degradable, or log Kow ≥ 3 (unless experimentally derived BCF ≤ 100).
R52: "Harmful to aquatic organisms."
– Acute toxicity > 10000 and ≤ 100,000 ppb.
R52 and 53: ―Harmful to aquatic organisms and may cause long-term, adverse effects in the
aquatic environment.‖
– Acute toxicity >10000 ppb and ≤ 100000 ppb and the compound is not readily
degradable, or log Kow ≥ 3(unless experimentally derived BCF ≤100).
R53: ―May cause long-term adverse effects in the aquatic environment.‖
– Solubility less than 1000 ppb, not readily degradable, or log Kow ≥3 (unless
experimentally derived BCF ≤ 100).

Simply based on the EC50s ethinyl estradiol was very toxic (R50) in C. dubia (400 ppb)
and in M. bahia (600 ppb). Ethinyl estradiol is toxic (R51) to D. pulex (6000 ppb) and M.
beryllina (2000 ppb) and harmful (R52) to P. promelas (10000 ppb).
Simply based on the acute toxicity fluoxetine was very toxic (R50) to all test organisms:
C. dubia (5 ppb), P. promelas (200 ppb), D. pulex (200 ppb), M. bahia (500 ppb), and M.
beryllina (500 ppb).
Table 17. Expected toxicity classification based on the Annex VI to the European Community
legislation of EE2 and FLX according to EC50 results of the current study.
EE2
FLX
Toxic
Toxic
Organism
EC50
Classification
EC50
Classification
Potential
Potential
(ppb)
(ppb)
C. dubia

400

R50

very toxic

5

R50

very toxic

D. pulex

6000

R51

toxic

200

R50

very toxic

P.
promelas

10000

R52

harmful

200

R50

very toxic

M. bahia

600

R50

very toxic

500

R50

very toxic

M.
beryllina

2000

R51

toxic

600

R50

very toxic
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The solubility of ethinyl estradiol in water was reported as 11.3 x 104 ppb (Yalkowsky
and Dannenfelser 1992). The maximum solubility of fluoxetine in water was noted as 14 x 106
ppb (O'Neil 2001). Additional solubilities were reported as and 15.0 x 106, 6.84 x 106, and 5.47
x 106 in the respective pHs of 5, 7, and 9 (Eli Lilly and Company 2005). Therefore, both drugs
―may cause long-term adverse effects in the aquatic environment‖ (R53) based on the fact that
their solubilities are less than 1000 ppb and not readily degradable.
The drugs may also be classified as R53 if the log Kow ≥3. The reported Log Kow for
ethinyl estradiol was 3.67 (Hansch et al. 1995) with a predicted log Kow of 4.12 using the
Ecological Structure Activity Relationships program (ECOSAR) (Sanderson et al. 2004).
Depending on which steroisomer is used for fluoxetine, the log Kow may differ slightly. For
example, Eli Lilly and Company (2005) reported the log Kow for fluoxetine as 1.0, 1.8, and 2.6 at
pH 5, 7, and 9 respectively. Brooks et al. (2003a) calculated values using ACD/Labs software
version 5.0 in Toronto, Ontario, Canada which included 1.25, 1.57, and 4.30 at pH 2, 7, and 11
respectively. ECOSAR predicted the log Kow of fluoxetine HCl as 4.65 (Sanderson et al. 2004).
Consequently, EE2 is classified as R53 based on the log Kow as is FLX at pHs greater than 9.
However, according to ECOSAR the log Kow of FLX is greater than 3 at any concentration.
The higher the log Kow (octanol-water coefficient) the more hydrophobic the compound
is and the greater probability for bioaccumulation. Lipophilic xenobiotics (log Kow >3) are
absorbed into fish bloodstream primarily across the gills (Kreke and Dietrich 2008).
Sublethal Effects of Ethinyl Estradiol and Fluoxetine
This study extended beyond lethality through the observation of sublethal effects which
are not required for acute test methods. Abnormalities observed during the test were
documented and concentration boundaries were established for sublethal effects. EE2 and FLX
induced effects on these standard EPA organisms.
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Alteration of serotonin, dopamine, and estrogenic hormones. Ethinyl estradiol and
fluoxetine have the potential to alter serotonin, dopamine, and estrogenic hormones. Therefore,
biological activities encompassing these chemicals could explain the various and in some cases,
similar behaviors/abnormalities observed in the current study. Estrogens also have the potential
increase serotonergic activity in Tilapia (Tsai and Wang 1997) and extracellular dopamine in
Rats (Disshon et al. 1998). Estrogens stimulate sensitivity of dopamine receptors in vertebrate
central nervous systems resulting in an increase of the catecholamine (Kelly et al. 2003;
Mermelstein et al. 1996). Knoll et al. (2000) demonstrated that in estrone (E1), dopamine release
is inhibited resulting in low levels of dopamine. However, Kelly and Wagner (1999) determined
that the natural estrogen E2 estradiol stimulates dopamine release resulting in more lethargic
activity.
Bymaster et al. (2002) state that norepinephrine and dopamine levels in mammals are
also increased after acute dosing with fluoxetine. Most SSRIs only increase the amount of
extracellular concentrations serotonin (Bymaster et al. 2002; Kreke and Dietrich 2008), thus
making FLX a unique pharmaceutical. Fluoxetine increased extracellular concentrations of
serotonin, norepinephrine and dopamine after acute dosing. The 242 nM concentration of
monoamines were sufficient to block 5-HT receptors which could explain the increase of
catecholamines (Bymaster et al. 2002).
Fluoxetine has significantly increased female circulating steroid concentrations in aquatic
organisms (Foran et al. 2004) perhaps causing organisms exposed to FLX to exhibit
abnormalities also seen after EE2 exposure.
Control of the circandian system. Under control of a number of neurotransmitters
including but not limited to serotonin and dopamine (Fingerman et al. 1994) are distal retinal
pigment hormones which modulate the amount of pigment present in the compound eyes. This
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enables organisms to adapt and differentiate between light and dark intensities (Beltz 1988). If
animals are unable to and measure and interpret day duration, necessary activities/functions
modified by the circandian system will be disrupted. Changes in normal body chemicals can
modify signaling pathways resulting in variations in behavior (Kreke and Dietrich 2008). As
evident by their swimming behavior, D. pulex and P. promelas appeared confused and
disoriented after EE2 exposure. This behavior was monitored in all test organisms exposed to
FLX. In this case it appears that there was a disruption in the organisms’ sensory perception due
to variations in neuromodulators.
Observed changes in behavior. Abnormal behaviors observed in all exposed organisms
included unresponsiveness, irregular swim patterns, erratic activity, convulsions, and changes in
aggression. Changes in locomotor activity could be the result of nueromodulatory effects
resulting from the dopaminergic levels following estrogenic administration (McGeea et al.
2009).
Generally speaking organisms exposed to ethinyl estradiol and fluoxetine demonstrated
lethargic behavior which became more pronounced as time and concentration increased. The
decrease in activity was correlated with the approaching mortality of the organisms. C. dubia and
P. promelas became lethargic during the first 24 hours of exposure with activity decreasing as
time and concentrations of EE2 increased. D. pulex and M. beryllina also displayed a decrease in
activity correlating with the increased time and concentrations with immobilization becoming
extremely prominent at 72 hours. All in all, as concentration increase immobilization became
more prominent. Studies by Jaser et al. (2003) observed swim inhibition in Ceriodaphnia
reticulate and Sida crystalline (water fleas) after 24 hours of exposure to ethinyl estradiol
yielding EC50s of 2000 ppb and less than 4000 ppb respectively.
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Table 18. Effects on catatonic behavior observed in test organisms resulting from ethinyl
estradiol or fluoxetine exposure.
Organism
Chemical
Catatonic behavior
Dose
(ppb)
Ceriodaphnia dubia
EE2
More prominent as time and
200 -7000
concentrations increased
Ceriodaphnia dubia.
FLX
More prominent as time and
20 – 200
concentrations increased
Daphnia pulex
EE2
More prominent as time and
> 300
concentrations increased
Daphnia pulex
FLX
Immobilization
200
More prominent as time and
500
concentrations increased
Pimephales promelas EE2
More prominent as time and
400 – 3000
concentrations increased
Pimephales promelas FLX
More prominent as time and
concentrations increased
Stationary vertical positioning 20 - 40
Menidia beryllina
EE2
More prominent as time and
100 – 3000
concentrations increased
Mysidopsis bahia
FLX
More prominent as time and
concentrations increased
Menidia beryllina
FLX
More prominent as time and
concentrations increased

Stanley et al. (2007) documented similar activity in which FLX caused immobilization in
Daphnia magna (water flea). P. promelas and M. beryllina exposed to fluoxetine were hovering
at the surface demonstrating very little activity beginning at test initiation. All crustaceans (water
fleas and M. bahia) were statically positioned around the edge of the beaker. In the current
study, P. promelas and M. beryllina demonstrated catatonic behavior and vertical positioning
which became more common in elevated concentrations as the test transpired. Gaworecki and
Klaine (2008) documented similar tendencies in hybrid striped bass exposed to 200 ppb of FLX.
In addition, elevated serotonin amounts, after exposure to SSRIs, have been connected with
submissive behavior in rainbow trout (Øverli et al. 2004) and in Japanese medaka which also
displayed nonresponsiveness (Foran et al. 2004). Western mosquitofish remained at the surface
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and lay on their sides with little or no swimming movement after acute exposure with lesser
concentrations producing less severe effects (Henry and Black 2008).
Initial increases of dopamine can cause agitation and aggression followed by depression.
Increased dopamine in the motor circuits will tend to produce random, involuntary movements
and muscle twitching along with possible abnormal posturing. After EE2 regiments, the restless
behavior of P. promelas included shaking and trembling which decreased with time and usually
ceased after 24 hours. The more severe tremors noted after larger dosing of EE2 and FLX in M.
beryllina correlated with fatality. These organisms exhibited apparent CNS toxicity
characterized by convulsing and seizing.
Impulsive and inconsistent activity was observed in D. pulex and P. promelas at the
beginning of the FLX test. Given the nature of dopamine, it would be assumed that activity
would increase as shown by the rotations and spiraling observed in D. pulex exposed to FLX and
M. bahia administered both drugs. Coiled swimming was associated with the warped tails and/or
spines of P. promelas subjected to both drugs and M. bahia administered FLX.
All species exhibited fits of agitation in higher concentrations of FLX which could be due
to increased dopamine levels during first 24 hours. Jumpiness was observed in all species at
lesser concentrations of FLX and ceased quickly with time. Lower concentrations of FLX
launched restless behavior of marine organisms in just 24 hours. For water fleas, restless
behavior in lower concentrations of FLX began at 96 hours.
Table 19. Effects on abnormal behavior observed in test organisms resulting from ethinyl
estradiol or fluoxetine exposure.
Organism
Chemical
Abnormal Behavior
Dose
(ppb)
Ceriodaphnia dubia
FLX
Very active and anxious
7
Daphnia pulex
EE2
Swimming around the
300 and 1000
parameter of the beaker
Crashed into the sides of the
5000
beakers and attempted escape
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(Table 19 continued)
Organism
Daphnia pulex

Pimephales promelas

Chemical
FLX

EE2

Abnormal Behavior

Dose
(ppb)

Jerky swimming motions

60

Combating and/or mating
Rotating backwards

100

Swimming in circles around
beaker
Frantic
Swimming inconsistently
throughout the water column

800
400 and 2000

Jumpy

Pimephales promelas

Mysidopsis bahia

FLX

FLX

Menidia beryllina

EE2

Menidia beryllina

FLX

Disoriented
Stationary vertical positioning
Disoriented

20 – 40
10 – 90

Restless behavior
Corkscrew swimming pattern
More active

90 – 200
190

Tumbling
Crooked tails
Extremely restless behavior
Flipping backwards
Convulsions and Seizures
Agitation
Convulsions and seizures

100 and 800
100
400
2000
2000 and 3000
Higher
concentrations
900 and 2000

Observed changes in feeding. The neurotransmitter serotonin additionally functions as
a hormone which can directly impact the immune system and alter appetite (Fent et al. 2006;
Barton et al. 2002). Goldfish showed a significant reduction in food intake when injected with 5HT (serotonin) (de Pedro et al. 1998). Exposure to FLX decreased growth and feeding rates in
fathead minnow (Stanley et al. 2007). In the current study, M. bahia decreased feeding in 10002000 ppb EE2 and at concentrations above 200 ppb FLX.
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Table 20. Effects on feeding habits observed in test organisms resulting from ethinyl estradiol or
fluoxetine exposure.
Organism
Chemical
Response
Dose
(ppb)
Decreased feeding
1000-2000
Mysidopsis bahia
EE2
Artemia, were alive
1000-2000
and very active
Mysidopsis bahia
FLX
Decreased feeding
> 200

Observed changes in aggression. Metcalfe et al. (2001) deduce that serotonin is the
antiaggressive agent in fish. The increased concentrations of EE2 and FLX caused a decrease in
probing and hostility in P. promelas and M. bahia. Those allotted higher concentrations of these
drugs ceased this disruptive behavior usually within 24 hours. However, antagonism
documented in lower concentrations occurred closer to test termination. In accordance with
submissive activity, cannibalistic casualties also subsided. M. bahia are naturally cannibalistic;
these tendencies were observed in both tests. After EE2 exposure the absence of D. pulex and
the apparent mutilation of deceased P. promelas were assumed to be prompted by the surviving
organisms.
Some aquatic species require aggressive behaviors to define hierarchical status and
dominance in reproduction. By omitting these behaviors during sensitive periods of reduction,
genetically less desirable organisms would mate arguably producing less desirable or unhealthy
offspring thus upsetting the balance of natural selection (Kreke and Dietrich 2008).
Table 21. Effects on aggressive behavior observed in test organisms resulting from ethinyl
estradiol or fluoxetine exposure.
Organism
Chemical
Response
Dose
(ppb)
Daphnia pulex
EE2
Missing organisms
300
Eaten by survivors
300 and 1000
Pimephales promelas
EE2
Aggressive and probing actions of 800 and 2000
inactive organisms
Damage and mutilation of
100 and 200
deceased
Injured underbelly
3000
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(Table 21 continued)
Organism

Chemical

Pimephales promelas
Mysidopsis bahia

FLX
EE2

Mysidopsis bahia

FLX

Response
Probing of inactive organisms
Aggressive behaviors and hostility
Cannibalism
Cannibalism

Dose
(ppb)
90 – 200
80 and 1000
≤ 300 and ≥ 600
> 50 <

Observed changes in fecundity. C. dubia and D. pulex exhibited increase in fecundity
though sexual maturity is not expected to occur this early. Therefore, it can be assumed that
ethinyl estradiol stimulates egg production. A minute number of D. pulex were observed mating
in both EE2 and FLX; however this behavior cannot be confirmed. It is important to note that
although the Daphnia population is usually made up entirely of females, under times of stress
male daphnids are produced in relatively small numbers with the propriety to mate (EPA 2002).
As a response to stress, species may produce offspring as early as possible in order to ensure
survival (Jaser et al. 2003).
Table 22. Effects on fecundity or reproduction observed in test organisms resulting from ethinyl
estradiol exposure.
Organism
Response
Dose
(ppb)
Ceriodaphnia dubia
1 offspring in each container
200

Daphnia pulex

Larvae in the brood chamber
of deceased organisms
Offspring present
Offspring
Eggs in brood chamber
Ephippia
Eggs not released

400
600 and 3000
1000
> 3000
10000

Observed changes in growth and development. Accelerated maturation was observed
in C. dubia, D. pulex, P. promelas, and M. bahia by evidence of coloration and/or larval
classification exposed to EE2. The growth increase of C. dubia, D. pulex, and M. bahia assigned
lower concentrations can possibly be attributed to femization since females of these species are
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larger (EPA 2002). It was assumed that molting and growth was inhibited in these species at
higher concentrations based on size. Additionally, ephippia, typically released during the molt
cycle, were first observed within 24 hours to 10000 ppb on the tails of D. pulex. The process of
development and molting is managed by constituents of the endocrine system. Simazine, a
known endocrine disruptor, was shown to interfere with the molt cycle of D. pulex (Fitzmayer et
al. 1982).
Previously documented research shows that EE2 can have an effect on growth; however,
these organisms were exposed for longer periods of time than in the current study. Still, it
appeared that acute exposure to EE2 can affect growth. C. dubia in 7 ppb (NOEC for FLX
mortality) were larger than control organisms or those exposed to other concentrations. This low
dose may stimulate growth while higher doses may inhibit growth. It is difficult to make this
assumption because so many of the organisms died at elevated concentrations. D. pulex
demonstrated a different effect in which higher concentrations appeared to stimulate growth.
Table 23. Effects on growth and development observed in test organisms resulting from ethinyl
estradiol or fluoxetine exposure.
Organism
Chemical
Response
Dose
(ppb)
Ceriodaphnia dubia
FLX
Larger size
7
Daphnia pulex
EE2
Larger size
1000
Daphnia pulex
FLX
Larger size
900 and 1000
Pimephales promelas EE2
Accelerated maturation
Mysidopsis bahia
EE2
Larger size
200
Mysidopsis bahia
FLX
Larger size
190
Menidia beryllina
EE2
Accelerated maturation
100-200
Mature pigmentation
2000

Observed changes in color. A number of species exhibiting decrease or absence in
color after EE2 exposure was documented in Danio rerio (zebrafish) (Bogers et al. 2006),
Poecilia reticulate (guppy) (Nielsen and Baatrup 2006), and Pomatoschistus minutes (sand goby)
(Robinson et al. 2003). The dispersion or accumulation of pigment hormones determines the
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coloration of organisms. These chromatophores are under control of a number of
neurotransmitters including but not limited to serotonin and dopamine (Fingerman et al. 1994).
As concentrations of EE2 and FLX increased, pigmentation decreased in D. pulex, P. promelas,
M. bahia, and M. beryllina. Larval classification in EPA methods suggested that P. promelas in
levels above 800 ppb EE2 matured faster; however, they remained pale in color. Their apparent
transparency could stem from deprivation of hemoglobin (USEPA 2002). Henderson et al.
(1981) noted a hemoglobin deficiency in minnows exposed to Hydrazine, an endocrine disruptor
widely used in industrial manufacturing.
Table 24. Effects on pigmentation observed in test organisms resulting from ethinyl estradiol or
fluoxetine exposure.
Organism
Chemical
Response
Dose
(ppb)
Pimephales promelas EE2
Opaque pigmentation
> 800
Mysidopsis bahia

EE2

Denser coloration

200

Mysidopsis bahia

FLX

Decreased pigmentation

> 200

Menidia beryllina

EE2

Denser pigmentation at
the head
Mature pigmentation

100-200
2000

Observed abnormalities. After EE2 exposure P. promelas had spinal deformities.
Deformation of the vertebrae after estrogen dosing was reported in Fundulus heteroclitus
(mummichog) and Pimephales promelas (fathead minnow) (Lange et al. 2001; Warner and
Jenkins 2007). Lange et al. (2001) also reported the occurrence of distended abdomens.
Protruding abdomens occurred in D. pulex, P. promelas, and M. beryllina and became more
pronounced at elevated concentrations of EE2. Interestingly, swollen abdomens in these species
were also triggered with FLX dosing. Fluoxetine also caused warped vertebrae in P. promelas
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and M. bahia. Foran et al. (2004) reported that Japanese medaka exposed to FLX also possessed
spinal curvatures.
Table 25. Abnormalities observed in test organisms resulting from ethinyl estradiol or fluoxetine
exposure.
Organism
Chemical
Response
Dose
(ppb)
Daphnia pulex
EE2
Cloudy water
10000
Daphnia pulex
FLX
Engorged abdomens
900 and 1000
Pimephales promelas EE2
Engorged swim bladders
3000

Pimephales promelas

FLX

Injured underbelly
Engorged abdomens

90 – 200

Crooked spines

Menidia beryllina
Menidia beryllina

EE2
FLX

Larger and lighter swim bladders
Engorged abdomens
Engorged abdomens

200-400

A rationalization of the abdominal protrusion occurring in the two fish species could be
due to possible overinflation of swim bladders. A swim bladder or air bladder is a large, thinwalled sac located in the dorsal portion of the body cavity that functions as a buoyant float, a
sound producer and receptor, and a respiratory organ. It allows the fish to move up and down
through the water column and remain at a specific water depth without wasting energy
swimming. The fish exposed to both drugs had lighter colored swim bladders thus enforcing the
idea that hemoglobin is lacking. Hemoglobin allows fish to fill or empty the swim bladder. This
organ is mostly inflated at night when organisms trying to escape predators rise to the surface of
the water and take in air (Büke et al. 2005). The circandian rhythmic offset due to changes in
serotonin amounts could explain why the organisms were floating on the surface. Overinflation
of the swim bladder causes organisms to float to the surface of the water and in turn they die of
starvation because they stop eating (Chatain 1994; Planas and Cunha 1999) as observed after
EE2 and FLX exposure. High levels of catecholamines have been closely linked to Swim
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bladder Stress Syndrome (SBSS), characterized by overinflation of the swim bladder, in which
no other anatomical alterations are apparent (Kolbeinshavn & Wallace 1985). Generally,
observed swim bladder size increased as concentrations increased.
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CONCLUSIONS
Every year people use thousands of tons of drugs to treat illnesses, to prevent unwanted
pregnancy, or to face the stresses of modern life. This appraisal is steadily increasing at an
exponential rate. The actual amounts consumed are based on estimates and are probably much
more abundant than reported because annual sales data does not include internet sales. Even after
extensive metabolism these reasonably stable active pharmaceutical ingredients are typically
unaltered with large portions of the parent compound being excreted. The metabolites may return
to the original parent compound either during sewage treatment or through environmental
transformations. Sewage treatment plants are not designed to remove pharmaceuticals and the
active pharmaceutical ingredients are conceived to withstand degradation. These oppositions
increase the potential for these compounds to remain in animal tissue and bioaccumulate
enforcing biomagnifications and bioconcentrations. Moreover, the pharmaceutical industry is
producing more effective active APIs by increasing potency, bioavailability, and degradation
resistance. For these reasons they should be regarded as contaminants of concern.
In terms of other man-made pollutants environmental pollutants, pharmaceuticals
exemplify a minuscule fraction of harmful contaminants present in the aquatic environment.
Ethinyl estradiol and fluoxetine, two of the most popular pharmaceuticals in the United States
have been available for decades, making them present in the environment since their introduction
to the market. Because APIs are typically present in extremely low concentrations it is through
recent advances in analytical instrumentation and techniques that their incidence has been
validated. This does not belittle APIs potential to cause harm to the environment because
pharmaceuticals are formulated to generate maximum responses at minimal amounts.
Environmental concern is not exclusively based on high production rates. Risk
assessment focuses on the chemicals’ properties and behavior in the environment such as
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degradation resistance, accumulation potential, toxicity potential, and effectiveness on biological
key functions such as hormone interference, reproduction, growth disturbance, etc. which are all
properties of EE2 and FLX.
After test termination, mortality curves were analyzed to quantify 96 hour EC50s,
NOECs, LOECs, and Ch.V.s for each of exposed to ethinyl estradiol and fluoxetine. Additionally
the acute toxic responses were assessed, compared, and contrasted for the five standard EPA test
organisms.
A broad range of effects and the ability for bodily chemicals to neutralize and return to
normal after exposure suggests that a traditional dose-response relationship may not be expected.
Higher mortality did not always correlate with increased concentration as evident by the
hormetic responses of organisms: P. promelas and M. beryllina and a slightly in D. pulex and
M. bahia after EE2 exposure and in C. dubia at 48 hours (causing 100% mortality at 96 hours)
and in M. bahia after FLX exposure and slightly in D. pulex. A normal dose-response was
observed in dose-response plots of C. dubia exposed to ethinyl estradiol and in D. pulex, P.
promelas, and M. beryllina exposed to fluoxetine.
At a similar EE2 concentration of 2000 ppb, mortalities included P. promelas (8%), D.
pulex (30-20%), M. beryllina (42.5%), M. bahia (95-100%) and C. dubia (100%).
The mortalities at 100 ppb of FLX included D. pulex (10%), P. promelas (3-40%), M.
beryllina (20%), M. bahia (47.5 – 45%), and C. dubia (60%).
The lowest concentrations of EE2 causing 100% mortality were as follows: C. dubia
(900 ppb), M. bahia (2000 ppb), M. beryllina (3000 ppb), P. promelas (8000 ppb), and D. pulex
(10000 ppb).
The lowest concentration of FLX causing 100% were as follows: C. dubia (20 ppb), P.
promelas (400 ppb), D. pulex (900 ppb), M. bahia (1000 ppb), and M. beryllina (2000 ppb).
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EE2 yielded higher EC50s and has been detected at levels greater than FLX which
produced lower lethal concentrations. The most sensitive species depends on the endpoint. C.
dubia is the most sensitive species based on EC50 for EE2 and FLX. Based on EC50 the most
resilient species was P. promelas for EE2 and M. beryllina for FLX.
The most sensitive species based on EC50 EE2: C. dubia (400 ppb) > M. bahia (600
ppb) > M. beryllina (2000 ppb) > D. pulex (6000 ppb) > P. promelas (10000 ppb).
The most sensitive species based on EC50 of FLX: C. dubia (5 ppb) > P. promelas (200
ppb) > D. pulex (200 ppb) > M. bahia (500 ppb) > M. beryllina (500 ppb).
The most sensitive species exposed to EE2 based on chronic value: C. dubia (300 ppb) >
M. bahia (400 ppb) > M. beryllina (1000 ppb) > P. promelas (2000 ppb) > D. pulex (4000 ppb).
The most sensitive species exposed to FLX based on chronic value: M. bahia (70 ppb) >
P. promelas (100 ppb) > C. dubia (200 ppb) > D. pulex (200 ppb) > M. beryllina (300 ppb).
The Ch.V. is based on the ratio of the NOEC and LOEC; because it is the concentration
that is considered ―safe‖ it should be lower than EC50. This rule pertains to all organisms
exposed to EE2. Freshwater species exposed to FLX broke this rule which can be explained on a
case by case situation. While still following the rule, the marine species exhibited much higher
EC50s. This can be attributed to the disruption in dose-response of M. bahia and M. beryllina
and the fact that the LOEC is not the first significantly different concentration.
Target receptors and/or biomolecules are present in humans and mammals are also
present a number of vertebrate and invertebrate nontarget organisms. Hence, these nontarget
organisms can potentially experience similar effects documented in mammalian toxicity tests.
These two drugs presented unanticipated and in many cases similar effects to the
organisms even after 96 hours. Exposure to these chemicals can potentially alter levels of
serotonin and dopamine and affect hormone production consequently signaling changes in
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behavior and normal development. Changes in behavior could be due to nueromodulatory
effects attributable to the changes in dopamine and serotonin levels. M. beryllina exhibited CNS
toxicity characterized by convulsing and seizing which correlated with fatality in both drugs.
Normal activity decreased with increased concentration and time (all org. all drugs).
Abnormal behaviors observed in both chemicals included unresponsiveness, irregular swim
patterns, erratic activity, and decreased aggression. All in all, as concentration increase
immobilization became more prominent for both drugs.
Both chemicals caused distended abdomens in P. promelas M. beryllina, and D. pulex.
This affected swim behavior in the sense that as abdomen became more pronounced,
immobilization was more prominent. Also affecting swim behavior was the spinal deformities
observed in M. bahia exposed to FLX and P. promelas after exposure to both drugs.
Naturally cannibalistic M. bahia exhibited decreases in feeding and aggression when
exposed to elevated concentrations of both pharmaceuticals. Cannibalisms occurred at higher
concentrations for EE2 and FLX. Aggression decreased with concentration and time in M. bahia
exposed to both drugs. P. promelas began probing less active organisms in both drugs.
Organisms in lower concentrations ceased this activity but continued in elevated doses.
P. promelas FLX aggression increased with time in lower concentrations.
Some aquatic species require aggressive behaviors to define hierarchical status and
dominance in reproduction. Modifications in any essential behaviors as well as transformations
in growth and development during sensitive periods of reduction could lead to genetically less
desirable organisms to mate. Arguably less desirable or unhealthy offspring would be produced
thus upsetting the balance of natural selection. The two species of water fleas (C. dubia and D.
pulex) exhibited different mortality curves but both displayed induction of fecundity when
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exposed to EE2. Although M. bahia demonstrated a similar in mortality curve to C. dubia,
mysid did not exhibit any offspring after EE2.
Ethinyl estradiol accelerated maturation in lower concentrations. Because the test
organisms, have relatively short life cycles, are not supposed to mature this fast. Higher
concentrations increased maturity a slightly but delayed growth possibly by decreasing the
ability to molt. The lower concentrations produced larger C. dubia, D. pulex, and M. bahia.
Organisms exposed to higher concentrations of EE2 and FLX lacked pigment, except one M.
beryllina exposed to EE2 in which case exhibited maturity by coloration.
The hypothesis was that complex organisms would exhibit less lethality at higher
concentrations. As this hold true in some cases. P. promelas was the most resilient species based
on similar concentrations and the EC50. D. pulex was the most resilient in terms of 100% and
Ch.V. C. dubia was the most sensitive in terms of similar concentration, 100% mortality, EC50,
and Ch.V.
The results in the present study confirm pharmaceuticals can produce lethality of nontarget organisms through acute exposure. Similar mortality patterns were observed between C.
dubia and M. bahia and between P. promelas, D. pulex, and M. beryllina.
It was expected that similar species would exhibit similar mortalities to one another.
While exposure to EE2 caused C. dubia and M. bahia (both crustaceans) to exhibit similarities in
terms of similar dose-response, EC50s, and Ch.V.s, the D. pulex (the other species of water flea)
was much more resilient and in some cases the most resilient organism. The two fish species had
similarities in the dose response curve. At 3000 ppb M. beryllina had 100% mortality while P.
promelas had only 40% mortality making it very resilient. Interestingly at the lesser
concentrations, 100 - 800 ppb both fish exhibited identical hormetic changes in mortality. It
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appears that D. pulex sensitivities were in between these two fish in similar concentrations and
EC50. The sensitivities were higher than fish in 100% and Ch.V. In all cases though,
M. beryllina was more sensitive than P. promelas and D. pulex. In all cases C. dubia was most
sensitive with M. bahia being the second most sensitive.
Exposure to FLX caused C. dubia to be the most sensitive in 100%, similar
concentration, and EC50. In Ch.V. M. bahia was the most sensitive with C. dubia being 3rd.
The most resilient species in 100% and EC50, and Ch.V. was M. beryllina, The most resilient
based on similar concentrations was D. pulex. In 100% D. pulex and M. bahia (crustaceans)
were similar along with M. beryllina. All these were more resilient than C. dubia and P.
promelas. In similar concentrations, D. pulex had similar mortalities to the two fish which were
more sensitive than the water flea. The C. dubia and M. bahia were similar. D. pulex and P.
promelas were similar in EC50 with the other freshwater species being most sensitive. However,
C. dubia had an EC50 closer to P. promelas. The two marine species, M. bahia and M. beryllina
were similar in EC50s.
It has been apparent that these pharmaceuticals not only elicit lethality but also abnormal
behaviors that have a number of possible explanations or in some cases, cannot be explained.
Simply observing lethality alone is not a sufficient enough endpoint to determine potential
effects on environment. It is the unpredicted effects that are causing harm to ecosystems. Ethinyl
estradiol and fluoxetine have the potential to alter serotonin, dopamine, and estrogenic
hormones. Therefore, biological activities encompassing these chemicals could explain the
various and in some cases, similar behaviors/abnormalities observed in the current study.
Abnormal behaviors observed in all exposed organisms included unresponsiveness, irregular
swim patterns, erratic activity, convulsions, and changes in aggression. Generally speaking
organisms exposed to ethinyl estradiol and fluoxetine demonstrated lethargic behavior which
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became more pronounced as time and concentration increased. All in all, as concentration
increase immobilization became more prominent. Generally, observed swim bladder size
increased as concentrations increased.
Traditional toxicity tests are designed usually designated specific mortality endpoints to
assess. More specific toxicity analysis should be developed implementing the available
knowledge that is generated during the pharmaceutical drug development process (e.g.
mechanisms of action, pharmacokinetic behavior and metabolism, target organs and side effects
in mammals).
Aside from the major mode of action, which in many cases are completely understood for
humans, pharmaceuticals have multiple minor modes of actions. However, given what we do
know about the drugs, experiments should be targeted towards known target modes of action
based on the assumption of similar modes of action in different species. Although a
pharmaceutical is projected to execute a specific pathway does not mean it will; the present study
has confirmed this idea. Nontarget tissues and organs can become disrupted complicating the
strategy to analyze potential effects.
Although animals are exposed to a multitude of chemical combinations, studies rarely
give effects on mixtures because it is difficult to evaluate which drug may cause which
unanticipated effect. It is important to understand how these drugs act as single exposure before
taking into account mixtures. These time consuming tests are much more complex, extensive,
and expensive and usually only justifiable at environmentally present concentrations. Also
mixture effects are most often anticipated by the idea of concentration addition in which the
combined toxicity is derived from the addition of the individual concentrations of each
compound. With this said, in the current study, species exhibited similar sublethal endpoints in
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both drugs. With this in mind, hypothetically concentrations that do not illicit lethality can cause
sublethal effects and based on additions can occur at environmentally detected levels.
It is difficult to anticipate outcomes based solely upon the drug’s intentional function or
an organism’s classification. Simple observations during acute tests can aid in analysis for
environmental risk and eventually aid in quantifying/development for new test regulations. Even
though some effects may not be statistically relevant this does not lessen their importance. Even
subtle alterations in normal life progressions, control the promise to directly or indirectly affect
entire populations or species. Disturbances in the environmental balance can bring about
catastrophes or unanticipated deteriorations of entire ecosystems.
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